US 8,409,093 B2Grant
Assessing measures of glycemic variability
Issue Date:2013-04-02
•26 Claims
•12 Drawing Sheets
Abstract
Methods, devices and systems for receiving an instruction to determine a glycemic variation level, retrieving a stored metric for determining the glycemic variation level, retrieving one or more parameters associated with the retrieved metric analysis, determining the glycemic variation level based on the retrieved one or more parameters for the retrieved metric analysis, and outputting the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved metric analysis meets a predetermined condition are disclosed.
Metadata
Assignee
- Abbott Diabetes Care Inc.
Inventor
- Jolyon R. Bugler
Application Information
Application Number:US 12/257,353
Filing Date:2008-10-23
Priority Date:2007-10-23
Art Unit:3735
Classifications
IPC:
A61B5/00A61B5/05
Patent Drawings (12 sheets)
Description
Related Application
[0001] The present application claims priority under 35 U.S.C. §119(e) to U.S. provisional application No. 60/982,110 filed Oct. 23, 2007, entitled “Assessing Measures Of Glycemic Variability”, and assigned to the Assignee of the present application, Abbott Diabetes Care, Inc. of Alameda, Calif., the disclosure of which is incorporated herein by reference for all purposes.
Background
[0002] Analyte, e.g., glucose monitoring systems including continuous and discrete monitoring systems generally include a small, lightweight battery powered and microprocessor controlled system which is configured to detect signals proportional to the corresponding measured glucose levels using an electrometer, and RF signals to transmit the collected data. One aspect of certain analyte monitoring systems include a transcutaneous or subcutaneous analyte sensor configuration which is, for example, partially mounted on the skin of a subject whose analyte level is to be monitored. The sensor cell may use a two or three-electrode (work, reference and counter electrodes) configuration driven by a controlled potential (potentiostat) analog circuit connected through a contact system.
[0003] The analyte sensor may be configured so that at least a portion thereof is placed under the skin of the patient so as to detect the analyte levels of the patient. In embodiments in which a portion is below the skin and a portion is above, the portion above the skin may be directly or indirectly connected with the transmitter unit. The transmitter unit is configured to transmit the analyte levels, e.g., in the form of current, detected by the sensor over a wireless (or wired) communication link such as an RF (radio frequency) communication link to a receiver/monitor unit. The receiver/monitor unit performs data analysis, among others on the received analyte levels to generate information pertaining to the monitored analyte levels.
[0004] To obtain accurate data from the analyte sensor, calibration may be necessary. In certain instances, blood glucose measurements are periodically obtained using, for example, a conventional analyte test strip and blood glucose meter, and the measured blood glucose values are used to calibrate the sensors. Indeed, the patient may calibrate each new analyte sensor using for example, capillary blood glucose measurements. Due to a lag factor between the monitored data and the measured blood glucose values, an error may be introduced in the monitored data.
[0005] In view of the foregoing, it would be desirable to have a method and system for calibrating analyte sensors of an analyte monitoring system to account for such lag errors in analyte monitoring systems.
Summary
[0006] In particular embodiments, methods, devices and systems for receiving an instruction to determine a glycemic variation level, retrieving a stored metric for determining the glycemic variation level, retrieving one or more parameters associated with the retrieved metric analysis, determining the glycemic variation level based on the retrieved one or more parameters for the retrieved metric analysis, and outputting the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved metric analysis meets a predetermined condition are disclosed.
[0007] These and other objects, features and advantages of the present disclosure will become more fully apparent from the following detailed description of the embodiments, the appended claims and the accompanying drawings.
Brief Description of the Drawings
[0008] FIG. 1 illustrates a block diagram of a data monitoring and management system for practicing one or more embodiments of the present disclosure;
[0009] FIG. 2 is a block diagram of the transmitter unit of the data monitoring and management system shown in FIG. 1 in accordance with one embodiment of the present disclosure;
[0010] FIG. 3 is a block diagram of the receiver/monitor unit of the data monitoring and management system shown in FIG. 1 in accordance with one embodiment of the present disclosure;
[0011] FIG. 4 is a flowchart illustrating glycemic variability determination in accordance with one aspect of the present disclosure;
[0012] FIG. 5 is a flowchart illustrating glycemic variability determination in accordance with another aspect of the present disclosure;
[0013] FIG. 6 shows a sample subject estimation of metric analysis based on MAGE with decreasing excursions in one aspect;
[0014] FIG. 7 shows a sample subject estimation of metric analysis based on GRADE in one aspect;
[0015] FIG. 8 illustrates the overall glucose variability measures and estimation requirements for the experimental study;
[0016] FIG. 9 illustrates the number of days of continuously monitored glucose data to attain the estimation requirement;
[0017] FIG. 10 illustrates the glucose standard deviation analysis as the metric for glycemic variability assessment;
[0018] FIG. 11 illustrates the proportion of time analysis (in hours per day—in hypoglycemia or hyperglycemia) as the metric for glycemic variability assessment;
[0019] FIG. 12 illustrates the number of episodes per day analysis (in hypoglycemia and hyperglycemia) as the metric for glycemic variability assessment;
[0020] FIG. 13 illustrates the maximum excursion analysis for each hypoglycemic episode or hyperglycemic episode as the metric for glycemic variability assessment;
[0021] FIG. 14 illustrates the results of MAGE analysis as the metric for glycemic variability assessment;
[0022] FIG. 15 illustrates the results of the Lability Index analysis as the metric for glycemic variability assessment;
[0023] FIG. 16 illustrates the results of Kovachev Risk Score analysis as the metric for glycemic variability assessment; and
[0024] FIG. 17 illustrates the results of GRADE analysis as the metric for glycemic variability assessment.
Detailed Description
[0025] As described in further detail below, in accordance with the various embodiments of the present disclosure, there is provided a method and system for performing a glycemic variability assessment based on one or more metric analysis to provide a snapshot of a diabetic condition based on continuously monitored glucose data over a predetermined time period.
[0026] FIG. 1 illustrates a data monitoring and management system such as, for example, analyte (e.g., glucose) monitoring system 100 in accordance with one embodiment of the present disclosure. The subject invention is further described primarily with respect to a glucose monitoring system for convenience and such description is in no way intended to limit the scope of the invention. It is to be understood that the analyte monitoring system may be configured to monitor a variety of analytes, e.g., lactate, and the like. For example, analytes that may be monitored include but are not limited to, for example, acetyl choline, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase (e.g., CK-MB), creatine, DNA, fructosamine, glucose, glutamine, growth hormones, hormones, ketones, lactate, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid stimulating hormone, and troponin. The concentration of drugs, such as, for example, antibiotics (e.g., gentamicin, vancomycin, and the like), digitoxin, digoxin, drugs of abuse, theophylline, and warfarin, may also be monitored.
[0027] The analyte monitoring system 100 includes a sensor 101, a transmitter unit 102 directly or indirectly coupled to the sensor 101, and a primary receiver unit 104 which is configured to communicate with the transmitter unit 102 via a communication link 103. The primary receiver unit 104 may be further configured to transmit data to a data processing terminal 105 for evaluating the data received by the primary receiver unit 104. Moreover, the data processing terminal in one embodiment may be configured to receive data directly from the transmitter unit 102 via a communication link 106 which may optionally be configured for bi-directional communication.
[0028] Also shown in FIG. 1 is an optional secondary receiver unit 106 which is operatively coupled to the communication link and configured to receive data transmitted from the transmitter unit 102. Moreover, as shown in the Figure, the secondary receiver unit 106 is configured to communicate with the primary receiver unit 104 as well as the data processing terminal 105. Indeed, the secondary receiver unit 106 may be configured for bi-directional wireless communication with each of the primary receiver unit 104 and the data processing terminal 105. As discussed in further detail below, in one embodiment of the present disclosure, the secondary receiver unit 106 may be configured to include a limited number of functions and features as compared with the primary receiver unit 104. As such, the secondary receiver unit 106 may be configured substantially in a smaller compact housing or embodied in a device such as a wrist watch, for example. Alternatively, the secondary receiver unit 106 may be configured with the same or substantially similar functionality as the primary receiver unit 104, and may be configured to be used in conjunction with a docking cradle unit for placement by bedside, for night time monitoring, and/or bi-directional communication device.
[0029] Only one sensor 101, transmitter unit 102, communication link 103, and data processing terminal 105 are shown in the embodiment of the analyte monitoring system 100 illustrated in FIG. 1 . However, it will be appreciated by one of ordinary skill in the art that the analyte monitoring system 100 may include one or more sensor 101, transmitter unit 102, communication link 103, and data processing terminal 105. Moreover, within the scope of the present disclosure, the analyte monitoring system 100 may be a continuous, semi-continuous, or a discrete monitoring system. In a multi-component environment, each device is configured to be uniquely identified by each of the other devices in the system so that communication conflict is readily resolved between the various components within the analyte monitoring system 100.
[0030] In one embodiment of the present disclosure, the sensor 101 is physically positioned in or on the body of a user whose analyte level is being monitored. In one aspect, the sensor 101 may be configured to use one or more of coulometric, amperometric, potentiometric or conductimetric approaches to measure the analyte level being monitored. The sensor 101 may be configured to continuously sample the analyte of the user and the sampled analyte may be converted into a corresponding data signal for transmission by the transmitter unit 102. In one embodiment, the transmitter unit 102 is mounted on the sensor 101 so that both devices are positioned on the user's body. The transmitter unit 102 performs data processing such as filtering and encoding on data signals, each of which corresponds to a sampled analyte level of the user, for transmission to the primary receiver unit 104 via the communication link 103.
[0031] In one embodiment, the analyte monitoring system 100 is configured as a one-way RF communication path from the transmitter unit 102 to the primary receiver unit 104. In such embodiment, the transmitter unit 102 may transmit the sampled data signals received from the sensor 101 without acknowledgement from the primary receiver unit 104 that the transmitted sampled data signals have been received (in other embodiments there may be acknowledgement). For example, the transmitter unit 102 may be configured to transmit the encoded sampled data signals at a fixed rate (e.g., at one minute intervals or other interval) after the completion of the initial power-on procedure. Likewise, the primary receiver unit 104 may be configured to detect such transmitted encoded sampled data signals at predetermined time intervals. Alternatively, the analyte monitoring system 100 may be configured with a bi-directional RF (or otherwise) communication between the transmitter unit 102 and the primary receiver unit 104.
[0032] Additionally, in one aspect, the primary receiver unit 104 may include two sections. The first section is an analog interface section that is configured to communicate with the transmitter unit 102 via the communication link 103. In one embodiment, the analog interface section may include a RF receiver and an antenna for receiving and amplifying the data signals from the transmitter unit 102, which are thereafter, demodulated with a local oscillator and filtered through a band-pass filter. The second section of the primary receiver unit 104 is a data processing section which is configured to process the data signals received from the transmitter unit 102 such as by performing data decoding, error detection and correction, data clock generation, and data bit recovery.
[0033] In operation in certain embodiments, upon completing a power-on procedure if required, the primary receiver unit 104 is configured to detect the presence of the transmitter unit 102 within its range based on, for example, the strength of the detected data signals received from the transmitter unit 102 or a predetermined transmitter identification information. Upon successful synchronization with the corresponding transmitter unit 102, the primary receiver unit 104 is configured to begin receiving from the transmitter unit 102 data signals corresponding to the user's detected analyte level. More specifically, the primary receiver unit 104 in one embodiment is configured to perform synchronized time hopping with the corresponding synchronized transmitter unit 102 via the communication link 103 to obtain the user's detected analyte level.
[0034] Referring again to FIG. 1 , the data processing terminal 105 may include a personal computer, a portable computer such as a laptop or a handheld device (e.g., personal digital assistants (PDAs) telephone such as a cellular telephone), and the like, each of which may be configured for data communication with the receiver via a wired or a wireless connection. Additionally, the data processing terminal 105 may further be connected to a data network (not shown) for storing, retrieving and updating data corresponding to the detected analyte level of the user.
[0035] Within the scope of the present disclosure, the data processing terminal 105 may include an infusion device such as an insulin infusion pump or the like, which may be configured to administer a drug such as, for example insulin, to users, and which may be configured to communicate with the receiver unit 104 for receiving, among others, the measured analyte level. Alternatively, the receiver unit 104 may be configured to integrate an infusion device therein so that the receiver unit 104 is configured to administer insulin therapy to patients, for example, for administering and modifying basal profiles, as well as for determining appropriate boluses for administration based on, among others, the detected analyte levels received from the transmitter unit 102.
[0036] Additionally, the transmitter unit 102, the primary receiver unit 104 and the data processing terminal 105 may each be configured for bi-directional wireless communication such that each of the transmitter unit 102, the primary receiver unit 104 and the data processing terminal 105 may be configured to communicate (that is, transmit data to and receive data from) with each other via the wireless communication link 103. More specifically, the data processing terminal 105 may in one embodiment be configured to receive data directly from the transmitter unit 102 via the communication link 106, where the communication link 106, as described above, may be configured for bi-directional communication.
[0037] In this embodiment, the data processing terminal 105 which may include an insulin pump, may be configured to receive the analyte signals from the transmitter unit 102, and thus, incorporate the functions of the receiver 104 including data processing for managing the patient's insulin therapy and analyte monitoring. In one embodiment, the communication link 103 may include one or more of an RF communication protocol, an infrared communication protocol, a Bluetooth® enabled communication protocol, an 802.11x wireless communication protocol, or an equivalent wireless communication protocol which would allow secure, wireless communication of several units (for example, per HIPPA requirements) while avoiding potential data collision and interference.
[0038] FIG. 2 is a block diagram of the transmitter of the data monitoring and detection system shown in FIG. 1 in accordance with one embodiment of the present disclosure. Referring to the Figure, the transmitter unit 102 in one embodiment includes an analog interface 201 configured to communicate with the sensor 101 (FIG. 1 ), a user input 202, and a temperature detection section 203, each of which is operatively coupled to a transmitter processor 204 such as a central processing unit (CPU). As can be seen from FIG. 2 , there are provided (this is very specific—what if more or less contacts—no guard, etc.) four contacts, three of which are electrodes—work electrode (W) 210, guard contact (G) 211, reference electrode (R) 212, and counter electrode (C) 213, each operatively coupled to the analog interface 201 of the transmitter unit 102 for connection to the sensor unit 201 (FIG. 1 ). In one embodiment, each of the work electrode (W) 210, guard contact (G) 211, reference electrode (R) 212, and counter electrode (C) 213 may be made using a conductive material that may be applied in any suitable manner, e.g., printed or etched, for example, such as carbon, gold, and the like, which may be printed, or metal foil (e.g., gold) which may be etched.
[0039] Further shown in FIG. 2 are a transmitter serial communication section 205 and an RF transmitter 206, each of which is also operatively coupled to the transmitter processor 204. Moreover, a power supply 207 such as a battery is also provided in the transmitter unit 102 to provide the necessary power for the transmitter unit 102. Additionally, as can be seen from the Figure, clock 208 is provided to, among others, supply real time information to the transmitter processor 204.
[0040] In one embodiment, a unidirectional input path is established from the sensor 101 (FIG. 1 ) and/or manufacturing and testing equipment to the analog interface 201 of the transmitter unit 102, while a unidirectional output is established from the output of the RF transmitter 206 of the transmitter unit 102 for transmission to the primary receiver unit 104. In this manner, a data path is shown in FIG. 2 between the aforementioned unidirectional input and output via a dedicated link 209 from the analog interface 201 to serial communication section 205, thereafter to the processor 204, and then to the RF transmitter 206. As such, in one embodiment, via the data path described above, the transmitter unit 102 is configured to transmit to the primary receiver unit 104 (FIG. 1 ), via the communication link 103 (FIG. 1 ), processed and encoded data signals received from the sensor 101 (FIG. 1 ). Additionally, the unidirectional communication data path between the analog interface 201 and the RF transmitter 206 discussed above allows for the configuration of the transmitter unit 102 for operation upon completion of the manufacturing process as well as for direct communication for diagnostic and testing purposes.
[0041] As discussed above, the transmitter processor 204 is configured to transmit control signals to the various sections of the transmitter unit 102 during the operation of the transmitter unit 102. In one embodiment, the transmitter processor 204 also includes a memory (not shown) for storing data such as the identification information for the transmitter unit 102, as well as the data signals received from the sensor 101. The stored information may be retrieved and processed for transmission to the primary receiver unit 104 under the control of the transmitter processor 204. Furthermore, the power supply 207 may include a commercially available battery.
[0042] The transmitter unit 102 is also configured such that the power supply section 207 is capable of providing power to the transmitter for a predetermined minimum continuous operation time period and also with a predetermined minimum shelf life time period such as, for example, a minimum of about three months of continuous operation after having been stored for about eighteen months in a low-power (non-operating) mode. In one embodiment, this may be achieved by the transmitter processor 204 operating in low-power modes in the non-operating state, for example, drawing no more than approximately 1 μA of current. Indeed, in one embodiment, the final step during the manufacturing process of the transmitter unit 102 may place the transmitter unit 102 in the low-power, non-operating state (i.e., post-manufacture sleep mode). In this manner, the shelf life of the transmitter unit 102 may be significantly improved. Moreover, as shown in FIG. 2 , while the power supply unit 207 is shown as coupled to the processor 204, and as such, the processor 204 is configured to provide control of the power supply unit 207, it should be noted that within the scope of the present disclosure, the power supply unit 207 is configured to provide the necessary power to each of the components of the transmitter unit 102 shown in FIG. 2 .
[0043] Referring back to FIG. 2 , the power supply section 207 of the transmitter unit 102 in one embodiment may include a rechargeable battery unit that may be recharged by a separate power supply recharging unit (for example, provided in the receiver unit 104) so that the transmitter unit 102 may be powered for a longer period of usage time. Moreover, in one embodiment, the transmitter unit 102 may be configured without a battery in the power supply section 207, in which case the transmitter unit 102 may be configured to receive power from an external power supply source (for example, a battery) as discussed in further detail below.
[0044] Referring yet again to FIG. 2 , the optional temperature detection section 203 of the transmitter unit 102 is configured to monitor the temperature of the skin near the sensor insertion site. The temperature reading may be used to adjust the analyte readings obtained from the analog interface 201. The RF transmitter 206 of the transmitter unit 102 may be configured for operation in the frequency band of 315 MHz to 433 MHz, for example, in the United States. Further, in one embodiment, the RF transmitter 206 is configured to modulate the carrier frequency by performing Frequency Shift Keying and Manchester encoding. In one embodiment, the data transmission rate is 19,200 symbols per second, with a minimum transmission range for communication with the primary receiver unit 104.
[0045] Referring yet again to FIG. 2 , also shown is a leak detection circuit 214 coupled to the guard electrode (G) 211 and the processor 204 in the transmitter unit 102 of the data monitoring and management system 100. The leak detection circuit 214 in accordance with one embodiment of the present disclosure may be configured to detect leakage current in the sensor 101 to determine whether the measured sensor data are corrupt or whether the measured data from the sensor 101 is accurate.
[0046] FIG. 3 is a block diagram of the receiver/monitor unit of the data monitoring and management system shown in FIG. 1 in accordance with one embodiment of the present disclosure. Referring to FIG. 3 , the primary receiver unit 104 includes a blood glucose test strip interface 301, an RF receiver 302, an input 303, a temperature detection section 304, and a clock 305, each of which is operatively coupled to a receiver processor 307. As can be further seen from the Figure, the primary receiver unit 104 also includes a power supply 306 operatively coupled to a power conversion and monitoring section 308. Further, the power conversion and monitoring section 308 is also coupled to the receiver processor 307. Moreover, also shown are a receiver serial communication section 309, and an output 310, each operatively coupled to the receiver processor 307.
[0047] In one embodiment, the test strip interface 301 includes a glucose level testing portion to receive a manual insertion of a glucose test strip, and thereby determine and display the glucose level of the test strip on the output 310 of the primary receiver unit 104. This manual testing of glucose can be used to calibrate sensor 101. The RF receiver 302 is configured to communicate, via the communication link 103 (FIG. 1 ) with the RF transmitter 206 of the transmitter unit 102, to receive encoded data signals from the transmitter unit 102 for, among others, signal mixing, demodulation, and other data processing. The input 303 of the primary receiver unit 104 is configured to allow the user to enter information into the primary receiver unit 104 as needed. In one aspect, the input 303 may include one or more keys of a keypad, a touch-sensitive screen, or a voice-activated input command unit. The temperature detection section 304 is configured to provide temperature information of the primary receiver unit 104 to the receiver processor 307, while the clock 305 provides, among others, real time information to the receiver processor 307.
[0048] Each of the various components of the primary receiver unit 104 shown in FIG. 3 is powered by the power supply 306 which, in one embodiment, includes a battery. Furthermore, the power conversion and monitoring section 308 is configured to monitor the power usage by the various components in the primary receiver unit 104 for effective power management and to alert the user, for example, in the event of power usage which renders the primary receiver unit 104 in sub-optimal operating conditions. An example of such sub-optimal operating condition may include, for example, operating the vibration output mode (as discussed below) for a period of time thus substantially draining the power supply 306 while the processor 307 (thus, the primary receiver unit 104) is turned on. Moreover, the power conversion and monitoring section 308 may additionally be configured to include a reverse polarity protection circuit such as a field effect transistor (FET) configured as a battery activated switch.
[0049] The serial communication section 309 in the primary receiver unit 104 is configured to provide a bi-directional communication path from the testing and/or manufacturing equipment for, among others, initialization, testing, and configuration of the primary receiver unit 104. Serial communication section 104 can also be used to upload data to a computer, such as time-stamped blood glucose data. The communication link with an external device (not shown) can be made, for example, by cable, infrared (IR) or RF link. The output 310 of the primary receiver unit 104 is configured to provide, among others, a graphical user interface (GUI) such as a liquid crystal display (LCD) for displaying information. Additionally, the output 310 may also include an integrated speaker for outputting audible signals as well as to provide vibration output as commonly found in handheld electronic devices, such as mobile telephones presently available. In a further embodiment, the primary receiver unit 104 also includes an electro-luminescent lamp configured to provide backlighting to the output 310 for output visual display in dark ambient surroundings.
[0050] Referring back to FIG. 3 , the primary receiver unit 104 in one embodiment may also include a storage section such as a programmable, non-volatile memory device as part of the processor 307, or provided separately in the primary receiver unit 104, operatively coupled to the processor 307. The processor 307 may be configured to perform Manchester decoding as well as error detection and correction upon the encoded data signals received from the transmitter unit 102 via the communication link 103.
[0051] Additional detailed description of the continuous analyte monitoring system, its various components including descriptions of the transmitter, the receiver/display unit, data communication, calibration and sensor insertion, among others, are provided in U.S. Pat. No. 6,175,752 issued Jan. 16, 2001 entitled “Analyte Monitoring Device and Methods of Use”, and in application Ser. No. 10/745,878 filed Dec. 26, 2003 entitled “Continuous Glucose Monitoring System and Methods of Use”, each assigned to the Assignee of the present application, disclosure of each of which are incorporated herein by reference for all purposes.
[0052] In aspects of the present disclosure, a robust glycemic variability determination function is provided. In particular, in one aspect, based on the analyte data collected over a predetermined time period, glycemic variability may be determined using one or more defined metrics for analysis to provide, for example, a diabetic condition of a patient or a user of the analyte monitoring system at any given time. In one aspect, one or more metrics such as standard deviation analysis, proportion of time (for example, hours per day) analysis, number of episodes per day analysis, maximum excursion during episode analysis (for example, measured in mg/dL), Mean Amplitude of Glycemic Excursions (MAGE) analysis, Lability Index analysis, Kovatchev Risk Score (based, for example, on low/high glucose index), or Glycemic Risk Assessment Diabetes Equation (GRADE) analysis, may be used to determine glycemic variability based on continuously monitored glucose data received and stored from the analyte sensor 101, for example, by the processing and storage unit 307 of the receiver unit 104/105 (FIG. 1 ).
[0053] The determined glycemic variability information may be output to the user or the patient at the output/display unit 310 of the receiver unit 104/105 to provide, for example, a snapshot of the diabetic condition of the analyte monitoring system user or patient based on glucose data received from the analyte sensor 101. In this manner, a user or a patient may conveniently track or monitor his/her diabetic condition when sufficient glucose data has been received from the sensor.
[0054] FIG. 4 is a flowchart illustrating glycemic variability determination in accordance with one aspect of the present disclosure. Referring to FIG. 4 , when the receiver unit 104/105 detects a request for glycemic variability determination (410), one or more available metrics for determining glycemic variability information is retrieved (420), and presented to the user/patient (for example, on the output/display 310 of the receiver unit 104/105). Upon receiving an indication selecting one or more of the available metrics for glycemic variability determination (430), one or more parameters associated the selected metric for glycemic variability determination is retrieved (440). For example, in one aspect, when standard deviation analysis is selected as the metric for determining the glycemic variability information, the associated number of glucose data points for determining the glycemic variability information using the standard deviation analysis is retrieved. For example, in one aspect, the standard deviation analysis may be configured to require 50 days of glucose data points to provide an accurate glycemic variability information.
[0055] Referring to FIG. 4 , as shown, it is determined whether the retrieved parameter meets the selected metric threshold (450). That is, in one aspect, the processing and storage unit 307 of the receiver unit 104/105 may be configured to retrieve stored glucose data points for the past 50 days. When the glucose data points for performing the selected metric analysis is determined to be sufficient (i.e., the receiver unit 104/105 has glucose data points for at least the past prior 50 days), then the glycemic variability is determined based on the selected metric analysis and presented to the user or the patient, for example, output to the output/display 310 on the receiver unit 104/105 (460). On the other hand, if the retrieved parameter does not meet the selected metric threshold (450) (that is, there are less than 50 days of glucose data points available for the selected metric analysis), a failure notification is generated and output to the user or the patient (470).
[0056] As described above, in one aspect, depending upon the selected metric for glycemic variability determination, when the parameters associated with the selected metric is available (for example, the needed pool of glucose data points spanning a predetermined time period which may be programmed in the receiver unit 104/105), the user or the patient may be provided with a reliable and accurate information of the monitored diabetic condition. In one aspect, the parameters for each metric made available to the user or the patient for determining glycemic variability may be based on a pre-programmed threshold level for each metric to provide an acceptable accuracy level, and which may be adjusted or modified.
[0057] In a further aspect, the user input unit 303 (FIG. 3 ) of the receiver unit 104/105 may be provided with a dedicated button or selectable indicator for the glycemic variability determination. For example, a “hot key” may be assigned in a menu structure presented in the output/display 310 to provide user selectability of the glycemic variability function. In this manner, in addition to receiving real time monitored glucose information from the analyte monitoring system 100 (FIG. 1 ), a user or a patient may readily. easily, and accurately determine his/her glycemic variability. In yet a further aspect, the glycemic variability may be performed retrospectively at a remote terminal such as the data processing terminal 105 which may include a personal computer or a server terminal that has received and stored the monitored glucose data points.
[0058] FIG. 5 is a flowchart illustrating glycemic variability determination in accordance with another aspect of the present disclosure. Referring to FIG. 5 , when a request for glycemic variability information is received (510), the stored analyte data over a predetermined time period for the metric to determine glycemic variability is retrieved (520). Based on the retrieved analyte data, the glycemic variability is assessed using the metric, for example, programmed or associated with the glycemic variability determination function (530).
[0059] Thereafter, the determined glycemic variability information is generated (540) and then output to the user or the patient (550). That is, in one aspect, when a user, a patient or a healthcare provider wishes to view a snapshot of the user or patient's diabetic condition, the receiver unit 104/105 may be configured to perform glycemic variability determination based on pre-programmed metric. In one aspect, the pre-programmed metric may be changed or varied as a user configurable parameter. In addition, the parameters associated with the pre-programmed metric may be user configurable or varied by, for example, the user, the patient or the healthcare provider.
Experimental Results
[0060] The FreeStyle Navigator® Continuous Glucose Monitoring System was used continuously for at least 70 days by ninety subjects. One-minute glucose data over this time period were collected from each subject, and data for the initial 20 days were excluded from the variability assessment as not representative of the overall subject glucose variability. The analyte sensor was replaced every 5 days with a new sensor, and calibration of each sensor at the scheduled calibration times were performed, for example, using an in vitro blood glucose meter. Eight glycemic variability metrics were calculated for each study subject. A defined estimation accuracy requirement was predetermined and imposed in the study to set the number of days of continuously monitored data needed for each metric determination.
[0061] The eight glycemic variability assessment metrics included standard deviation analysis, proportion of time (for example, hours per day) analysis, number of episodes per day analysis, maximum excursion during episode analysis (for example, measured in mg/dL), Mean Amplitude of Glycemic Excursions (MAGE) analysis, Lability Index analysis, Kovatchev Risk Score (based, for example, on low/high glucose index), and Glycemic Risk Assessment Diabetes Equation (GRADE) analysis.
[0062] Based on subject analysis eligibility of more than 50 days of continuously monitored glucose data, 68 of the 90 subjects were eligible. For each subject, the true parameter value for each metric analysis was based on the value of the subject's glucose data after 50 days from the start of the continuous monitoring. The cumulative subject value for the metric analysis was defined daily based on all cumulative data for each day, where an acceptable parameter estimate was defined at cumulative value within +/−10% of the true parameter value. Also, the optimal days of continuously monitored glucose data to acceptable accuracy was defined for each subject as the first day at which the cumulative value remained within +/−10% of the subject's true parameter value.
[0063] FIG. 6 shows a sample subject estimation of metric analysis based on MAGE with decreasing excursions, with a standard deviation factor of 1.0 based on continuous glucose data collected over a time period of approximately 35 days after the initial 120 day period. FIG. 7 shows a sample subject estimation of metric analysis based on GRADE using continuously monitored glucose data over a time period of approximately 30 days after the initial 20 day period, showing the mean, standard deviation and the standard error.
[0064] FIG. 8 illustrates the overall glucose variability measures and estimation requirements for the study based on 90 subjects for each of the eight metric analysis performed. FIG. 9 illustrates the number of days of continuously monitored glucose data to attain the estimation requirement of 10% with the exclusion of data from the initial 20 day period for each of the eight metrics discussed above. FIGS. 10-17 illustrate the results of each of the eight metric analysis, respectively, over the time period of approximately 30 days after the initial 20 day period for glycemic variability assessment.
[0065] For example, FIG. 10 illustrates the glucose standard deviation analysis as the metric for glycemic variability assessment, FIG. 11 illustrates the proportion of time analysis (in hours per day—in hypoglycemia or hyperglycemia) as the metric for glycemic variability assessment, FIG. 12 illustrates the number of episodes per day analysis (in hypoglycemia and hyperglycemia) as the metric for glycemic variability assessment, FIG. 13 illustrates the maximum excursion analysis for each hypoglycemic episode or hyperglycemic episode as the metric for glycemic variability assessment, FIG. 14 illustrates the results of MAGE analysis as the metric for glycemic variability assessment, FIG. 15 illustrates the results of the Lability Index analysis as the metric for glycemic variability assessment, FIG. 16 illustrates the results of Kovachev Risk Score analysis as the metric for glycemic variability assessment showing low blood glucose index (LBGI) and high blood glucose index (HBGI), and FIG. 17 illustrates the results of GRADE analysis as the metric for glycemic variability assessment, each of these figures based on data collected from the subjects over the 30 day time period of continuous glucose monitoring.
[0066] In the manner described, in embodiments of the present disclosure, depending upon the metric analysis used for glycemic variability assessment, to achieve the desired accuracy level, the amount of continuously monitored data may vary. Accordingly, one or more parameters such as the number of days of available continuous glucose data for determining glycemic variability based on a selected or pre-programmed metric analysis may be modified or adjusted to achieve the desired accuracy level of glycemic variability level.
[0067] As discussed, within the scope of the present disclosure, the particular metric analysis (and/or associated parameters) for performing the glycemic variability assessment to illustrate a snapshot of a persons' diabetic condition may be defined or selected by the user, patient or the healthcare provider, or pre-programmed into the system (for example, the receiver unit 104/105, a computing device or computing terminal, a mobile telephone, a personal digital assistant, each configured to execute instructions to perform the metric analysis). Further, the device or system may be programmed such that when the underlying data is available for the selected metric analysis is insufficient (for example, when there is not enough collected glucose data from the analyte monitoring device), the glycemic assessment analysis may be disabled for the user, patient, or the healthcare provider may be notified that there is insufficient data pool (or one or more conditions for one or more metrics to determine the glycemic variability are not satisfied).
[0068] An apparatus in one aspect includes a memory configured to store one or more executable instructions, a control unit operatively coupled to the memory and configured to retrieve the one or more executable instructions for execution, an input unit operatively coupled to the control unit for inputting one or more instructions to the control unit to execute one or more routines, and an output unit operatively coupled to the control unit for outputting one or more information, the output unit including a glycemic variability indicator associated with a determined variation in a glycemic level, where the glycemic variability indicator is provided to the output unit when the glycemic variation data is determined to be sufficient for a selected one or more metric to determine glycemic variability.
[0069] The control unit in one aspect may include one or more of a microprocessor, an application specific integrated circuit, or a state machine.
[0070] The one or more metric may include one or more of a standard deviation, MAGE, GRADE, Lability index, a number of glycemic variation episode excursions, a duration of each glycemic variation episode excursion, an average maximum excursion value, or a low/high blood glucose index.
[0071] Also, the one or more glycemic variation episode excursion may include deviation from a predetermined hypoglycemic threshold parameter or from a predetermined hyperglycemic threshold parameter.
[0072] Further, each of the one or more metrics may include a predetermined amount of data associated with the metric for glycemic variability determination.
[0073] In a further aspect, glycemic variability indicator may be provided to the output unit only when the glycemic variation data is determined to be sufficient.
[0074] The glycemic variation data may include a number of glucose data samples. Also, the number of glucose data samples may be stored in the memory unit.
[0075] The apparatus may include a communication unit operatively coupled to the control unit, the communication unit configured to send or receive data to or from a remote location, and further, where the remote location may include one or more of a remote data processing terminal, an analyte monitoring system, a blood glucose meter device, a server terminal, a personal digital assistant, a mobile telephone, or a messaging device.
[0076] The communication unit may be configured for wired or wireless communication.
[0077] A method in one aspect may include receiving an instruction to determine a glycemic variation level, retrieving a stored metric for determining the glycemic variation level, retrieving one or more parameters associated with the retrieved metric analysis, determining the glycemic variation level based on the retrieved one or more parameters for the retrieved metric analysis, and outputting the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved metric analysis meets a predetermined condition.
[0078] The predetermined condition may include a predetermined stabilization level.
[0079] The determined glycemic variation level may be output only when it is determined that the retrieved one or more parameters meets the predetermined condition.
[0080] The predetermined condition may include availability of the number of glucose data over a predetermined time period.
[0081] The predetermined time period may be associated with the retrieved metric analysis.
[0082] Also, the glycemic variation level may be an output as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.
[0083] The method may also include storing the determined glycemic variation level.
[0084] Additionally, the method may include outputting an indication of unsuccessful glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved metric analysis does not meet the predetermined condition.
[0085] Again, the one or more metric analysis may include one or more of a standard deviation analysis, MAGE analysis, GRADE analysis, Lability index analysis, a number of glycemic variation episode excursions analysis, a duration of each glycemic variation episode excursion analysis, an average maximum excursion value analysis, or a low/high blood glucose index analysis.
[0086] An apparatus in a further aspect of the present disclosure may include a storage unit for storing one or more executable instructions, a microprocessor operatively coupled to the storage unit for accessing the one or more executable instructions, which, when executed receives an instruction to determine a glycemic variation level, retrieves a stored metric for determining the glycemic variation level, retrieves one or more parameters associated with the retrieved metric analysis, determines the glycemic variation level based on the retrieved one or more parameters for the retrieved metric analysis, and outputs the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved metric analysis meets a predetermined condition.
[0087] Various other modifications and alterations in the structure and method of operation of this invention will be apparent to those skilled in the art without departing from the scope and spirit of the invention. Although the invention has been described in connection with specific preferred embodiments, it should be understood that the invention as claimed should not be unduly limited to such specific embodiments. It is intended that the following claims define the scope of the present disclosure and that structures and methods within the scope of these claims and their equivalents be covered thereby.
Claims
What is claimed is:
1. A method, comprising:
receiving an instruction to determine a glycemic variation level;
retrieving a stored metric for determining the glycemic variation level;
retrieving one or more parameters associated with the retrieved stored metric;
determining, using one or more processors, the glycemic variation level based on the retrieved one or more parameters for the retrieved stored metric; and
outputting the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved stored metric meets a predetermined condition, wherein the predetermined condition includes a predetermined stabilization level.
2. The method of claim 1 wherein the determined glycemic variation level is output only when it is determined that the retrieved one or more parameters meets the predetermined condition.
3. The method of claim 1 wherein the predetermined condition includes availability of a number of glucose data over a predetermined time period.
4. The method of claim 3 wherein the predetermined time period is associated with the retrieved stored metric.
5. The method of claim 1 wherein the glycemic variation level is output as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.
6. The method of claim 1 including storing the determined glycemic variation level.
7. The method of claim 1 including outputting an indication of unsuccessful glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved stored metric does not meet the predetermined condition.
8. The method of claim 1 wherein the one or more stored metric includes one or more of a standard deviation analysis, Mean Amplitude of Glycemic Excursions (MAGE) analysis, Glycemic Risk Assessment Diabetes Excursion (GRADE) analysis, Lability index analysis, a number of glycemic variation episode excursions analysis, a duration of each glycemic variation episode excursion analysis, an average maximum excursion value analysis, or a low/high blood glucose index analysis.
9. The method of claim 1 wherein the one or more parameters includes at least one of a predetermined number of prior glucose data points and glucose data obtained over a predetermined time period.
10. An apparatus, comprising:
a storage unit for storing one or more executable instructions; and
a microprocessor operatively coupled to the storage unit for accessing the one or more executable instructions, which, when executed receives an instruction to determine a glycemic variation level, retrieves a stored metric for determining the glycemic variation level, retrieves one or more parameters associated with the retrieved stored metric, determines the glycemic variation level based on the retrieved one or more parameters for the retrieved stored metric, and outputs the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved stored metric meets a predetermined condition, wherein the predetermined condition includes a predetermined stabilization level.
11. The apparatus of claim 10 wherein the microprocessor operatively coupled to the storage unit for accessing the one or more executable instructions, which, when executed, outputs the determined glycemic variation level only when it is determined that the retrieved one or more parameters meets the predetermined condition.
12. The apparatus of claim 10 wherein the predetermined condition includes availability of a number of glucose data over a predetermined time period.
13. The apparatus of claim 12 wherein the predetermined time period is associated with the stored metric.
14. The apparatus of claim 10 wherein the microprocessor operatively coupled to the storage unit for accessing the one or more executable instructions, which, when executed, outputs the glycemic variation level as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.
15. The apparatus of claim 10 wherein the microprocessor operatively coupled to the storage unit for accessing the one or more executable instructions, which, when executed, stores the determined glycemic variation level.
16. The apparatus of claim 10 wherein the microprocessor operatively coupled to the storage unit for accessing the one or more executable instructions, which, when executed, outputs an indication of unsuccessful glycemic variation level when it is determined that the retrieved one or more parameters associated with the stored metric does not meet the predetermined condition.
17. The apparatus of claim 10 wherein the one or more stored metric includes one or more of a standard deviation analysis, Mean Amplitude of Glycemic Excursions (MAGE) analysis, Glycemic Risk Assessment Diabetes Excursion (GRADE) analysis, Lability index analysis, a number of glycemic variation episode excursions analysis, a duration of each glycemic variation episode excursion analysis, an average maximum excursion value analysis, or a low/high blood glucose index analysis.
18. The apparatus of claim 10 wherein the one or more parameters includes at least one of a predetermined number of prior glucose data points and glucose data obtained over a predetermined time period.
19. A method, comprising:
receiving an instruction to determine a glycemic variation level;
retrieving a stored metric for determining the glycemic variation level;
retrieving one or more parameters associated with the retrieved stored metric;
determining, using one or more processors, the glycemic variation level based on the retrieved one or more parameters for the retrieved stored metric;
outputting the determined glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved stored metric meets a predetermined condition; and
outputting an indication of unsuccessful glycemic variation level when it is determined that the retrieved one or more parameters associated with the retrieved stored metric does not meet the predetermined condition.
20. The method of claim 19 wherein the determined glycemic variation level is output only when it is determined that the retrieved one or more parameters meets the predetermined condition.
21. The method of claim 19 wherein the predetermined condition includes availability of a number of glucose data over a predetermined time period.
22. The method of claim 21 wherein the predetermined time period is associated with the retrieved stored metric.
23. The method of claim 19 wherein the glycemic variation level is output as one or more of an audible indication, a visual indication, a vibratory indication, or one or more combinations thereof.
24. The method of claim 19 including storing the determined glycemic variation level.
25. The method of claim 19 wherein the one or more stored metric includes one or more of a standard deviation analysis, Mean Amplitude of Glycemic Excursions (MAGE) analysis, Glycemic Risk Assessment Diabetes Excursion (GRADE) analysis, Lability index analysis, a number of glycemic variation episode excursions analysis, a duration of each glycemic variation episode excursion analysis, an average maximum excursion value analysis, or a low/high blood glucose index analysis.
26. The method of claim 19 wherein the one or more parameters includes at least one of a predetermined number of prior glucose data points and glucose data obtained over a predetermined time period.
Patent Citations (761)
| Patent | Date | Inventor | Cited By |
|---|---|---|---|
| US3581062(A) | 1971-05-01 | Aston | Applicant |
| US3926760(A) | 1975-12-01 | Allen et al. | Applicant |
| US3949388(A) | 1976-04-01 | Fuller | Applicant |
| US4036749(A) | 1977-07-01 | Anderson | Applicant |
| US4055175(A) | 1977-10-01 | Clemens et al. | Applicant |
| US4129128(A) | 1978-12-01 | McFarlane | Applicant |
| US4245634(A) | 1981-01-01 | Albisser et al. | Applicant |
| US4327725(A) | 1982-05-01 | Cortese et al. | Applicant |
| US4344438(A) | 1982-08-01 | Schultz | Applicant |
| US4349728(A) | 1982-09-01 | Phillips et al. | Applicant |
| US4373527(A) | 1983-02-01 | Fischell | Applicant |
| US4392849(A) | 1983-07-01 | Petre et al. | Applicant |
| US4425920(A) | 1984-01-01 | Bourland et al. | Applicant |
| US4431004(A) | 1984-02-01 | Bessman et al. | Applicant |
| US4478976(A) | 1984-10-01 | Goertz et al. | Applicant |
| US4494950(A) | 1985-01-01 | Fischell | Applicant |
| US4509531(A) | 1985-04-01 | Ward | Applicant |
| US4527240(A) | 1985-07-01 | Kvitash | Applicant |
| US4538616(A) | 1985-09-01 | Rogoff | Applicant |
| US4619793(A) | 1986-10-01 | Lee | Applicant |
| US4671288(A) | 1987-06-01 | Gough | Applicant |
| US4703756(A) | 1987-11-01 | Gough et al. | Applicant |
| US4731726(A) | 1988-03-01 | Allen, III | Applicant |
| US4749985(A) | 1988-06-01 | Corsberg | Applicant |
| US4757022(A) | 1988-07-01 | Shults et al. | Applicant |
| US4777953(A) | 1988-10-01 | Ash et al. | Applicant |
| US4779618(A) | 1988-10-01 | Mund et al. | Applicant |
| US4854322(A) | 1989-08-01 | Ash et al. | Applicant |
| US4871351(A) | 1989-10-01 | Feingold | Applicant |
| US4890620(A) | 1990-01-01 | Gough | Applicant |
| US4925268(A) | 1990-05-01 | Iyer et al. | Applicant |
| US4953552(A) | 1990-09-01 | DeMarzo | Applicant |
| US4986271(A) | 1991-01-01 | Wilkins | Applicant |
| US4995402(A) | 1991-02-01 | Smith et al. | Applicant |
| US5000180(A) | 1991-03-01 | Kuypers et al. | Applicant |
| US5002054(A) | 1991-03-01 | Ash et al. | Applicant |
| US5019974(A) | 1991-05-01 | Beckers | Applicant |
| US5050612(A) | 1991-09-01 | Matsumura | Applicant |
| US5055171(A) | 1991-10-01 | Peck | Applicant |
| US5068536(A) | 1991-11-01 | Rosenthal | Applicant |
| US5082550(A) | 1992-01-01 | Rishpon et al. | Applicant |
| US5106365(A) | 1992-04-01 | Hernandez | Applicant |
| US5122925(A) | 1992-06-01 | Inpyn | Applicant |
| US5165407(A) | 1992-11-01 | Wilson et al. | Applicant |
| US5202261(A) | 1993-04-01 | Musho et al. | Applicant |
| US5210778(A) | 1993-05-01 | Massart | Applicant |
| US5246867(A) | 1993-09-01 | Lakowicz et al. | Applicant |
| US5262035(A) | 1993-11-01 | Gregg et al. | Applicant |
| US5262305(A) | 1993-11-01 | Heller et al. | Applicant |
| US5264104(A) | 1993-11-01 | Gregg et al. | Applicant |
| US5264105(A) | 1993-11-01 | Gregg et al. | Applicant |
| US5279294(A) | 1994-01-01 | Anderson et al. | Applicant |
| US5285792(A) | 1994-02-01 | Sjoquist et al. | Applicant |
| US5293877(A) | 1994-03-01 | O'Hara et al. | Applicant |
| US5299571(A) | 1994-04-01 | Mastrototaro | Applicant |
| US5320725(A) | 1994-06-01 | Gregg et al. | Applicant |
| US5322063(A) | 1994-06-01 | Allen et al. | Applicant |
| US5330634(A) | 1994-07-01 | Wong et al. | Applicant |
| US5340722(A) | 1994-08-01 | Wolfbeis et al. | Applicant |
| US5342789(A) | 1994-08-01 | Chick et al. | Applicant |
| US5356786(A) | 1994-10-01 | Heller et al. | Applicant |
| US5360404(A) | 1994-11-01 | Novacek et al. | Applicant |
| US5372427(A) | 1994-12-01 | Padovani et al. | Applicant |
| US5379238(A) | 1995-01-01 | Stark | Applicant |
| US5390671(A) | 1995-02-01 | Lord et al. | Applicant |
| US5391250(A) | 1995-02-01 | Cheney, II et al. | Applicant |
| US5408999(A) | 1995-04-01 | Singh et al. | Applicant |
| US5411647(A) | 1995-05-01 | Johnson et al. | Applicant |
| US5425868(A) | 1995-06-01 | Pedersen | Applicant |
| US5429602(A) | 1995-07-01 | Hauser | Applicant |
| US5431160(A) | 1995-07-01 | Wilkins | Applicant |
| US5431921(A) | 1995-07-01 | Thombre | Applicant |
| US5462645(A) | 1995-10-01 | Albery et al. | Applicant |
| US5497772(A) | 1996-03-01 | Schulman et al. | Examiner |
| US5505828(A) | 1996-04-01 | Wong et al. | Applicant |
| US5507288(A) | 1996-04-01 | Bocker et al. | Applicant |
| US5509410(A) | 1996-04-01 | Hill et al. | Applicant |
| US5514718(A) | 1996-05-01 | Lewis et al. | Applicant |
| US5531878(A) | 1996-07-01 | Vadgama et al. | Applicant |
| US5552997(A) | 1996-09-01 | Massart | Applicant |
| US5568400(A) | 1996-10-01 | Stark et al. | Applicant |
| US5568806(A) | 1996-10-01 | Cheney, II et al. | Applicant |
| US5569186(A) | 1996-10-01 | Lord et al. | Applicant |
| US5582184(A) | 1996-12-01 | Erickson et al. | Applicant |
| US5586553(A) | 1996-12-01 | Halili et al. | Applicant |
| US5593852(A) | 1997-01-01 | Heller et al. | Applicant |
| US5609575(A) | 1997-03-01 | Larson et al. | Applicant |
| US5628310(A) | 1997-05-01 | Rao et al. | Applicant |
| US5653239(A) | 1997-08-01 | Pompei et al. | Applicant |
| US5660163(A) | 1997-08-01 | Schulman et al. | Applicant |
| US5665222(A) | 1997-09-01 | Heller et al. | Applicant |
| US5711001(A) | 1998-01-01 | Bussan et al. | Applicant |
| US5711861(A) | 1998-01-01 | Ward et al. | Applicant |
| US5733259(A) | 1998-03-01 | Valcke et al. | Applicant |
| US5772586(A) | 1998-06-01 | Heinonen et al. | Applicant |
| US5791344(A) | 1998-08-01 | Schulman et al. | Applicant |
| US5842189(A) | 1998-11-01 | Keeler et al. | Applicant |
| US5899855(A) | 1999-05-01 | Brown | Applicant |
| US5925021(A) | 1999-07-01 | Castellano et al. | Applicant |
| US5935224(A) | 1999-08-01 | Svancarek et al. | Applicant |
| US5942979(A) | 1999-08-01 | Luppino | Applicant |
| US5957854(A) | 1999-09-01 | Besson et al. | Applicant |
| US5964993(A) | 1999-10-01 | Blubaugh, Jr. et al. | Applicant |
| US5965380(A) | 1999-10-01 | Heller et al. | Applicant |
| US5971922(A) | 1999-10-01 | Arita et al. | Applicant |
| US5980708(A) | 1999-11-01 | Champagne et al. | Applicant |
| US5995860(A) | 1999-11-01 | Sun et al. | Applicant |
| US6001067(A) | 1999-12-01 | Shults et al. | Applicant |
| US6024699(A) | 2000-02-01 | Surwit et al. | Applicant |
| US6049727(A) | 2000-04-01 | Crothall | Applicant |
| US6083710(A) | 2000-07-01 | Heller et al. | Applicant |
| US6088608(A) | 2000-07-01 | Schulman et al. | Applicant |
| US6091976(A) | 2000-07-01 | Pfeiffer et al. | Applicant |
| US6093172(A) | 2000-07-01 | Funderburk et al. | Applicant |
| US6103033(A) | 2000-08-01 | Say et al. | Applicant |
| US6117290(A) | 2000-09-01 | Say et al. | Applicant |
| US6119028(A) | 2000-09-01 | Schulman et al. | Applicant |
| US6120676(A) | 2000-09-01 | Heller et al. | Applicant |
| US6121009(A) | 2000-09-01 | Heller et al. | Applicant |
| US6121611(A) | 2000-09-01 | Lindsay et al. | Applicant |
| US6122351(A) | 2000-09-01 | Schlueter, Jr. et al. | Applicant |
| US6134461(A) | 2000-10-01 | Say et al. | Applicant |
| US6162611(A) | 2000-12-01 | Heller et al. | Applicant |
| US6175752(B1) | 2001-01-01 | Say et al. | Applicant |
| US6200265(B1) | 2001-03-01 | Walsh et al. | Applicant |
| US6212416(B1) | 2001-04-01 | Ward et al. | Applicant |
| US6219574(B1) | 2001-04-01 | Cormier et al. | Applicant |
| US6233471(B1) | 2001-05-01 | Berner et al. | Applicant |
| US6248067(B1) | 2001-06-01 | Causey, III et al. | Applicant |
| US6275717(B1) | 2001-08-01 | Gross et al. | Applicant |
| US6284478(B1) | 2001-09-01 | Heller et al. | Applicant |
| US6293925(B1) | 2001-09-01 | Safabash et al. | Applicant |
| US6295506(B1) | 2001-09-01 | Heinonen et al. | Applicant |
| US6299347(B1) | 2001-10-01 | Pompei | Applicant |
| US6306104(B1) | 2001-10-01 | Cunningham et al. | Applicant |
| US6309884(B1) | 2001-10-01 | Cooper et al. | Applicant |
| US6329161(B1) | 2001-12-01 | Heller et al. | Applicant |
| US6360888(B1) | 2002-03-01 | McIvor et al. | Applicant |
| US6366794(B1) | 2002-04-01 | Moussy et al. | Applicant |
| US6377828(B1) | 2002-04-01 | Chaiken et al. | Applicant |
| US6379301(B1) | 2002-04-01 | Worthington et al. | Applicant |
| US6424847(B1) | 2002-07-01 | Mastrototaro et al. | Applicant |
| US6427088(B1) | 2002-07-01 | Bowman, IV et al. | Applicant |
| US6440068(B1) | 2002-08-01 | Brown et al. | Applicant |
| US6478736(B1) | 2002-11-01 | Mault | Applicant |
| US6484046(B1) | 2002-11-01 | Say et al. | Applicant |
| US6493069(B1) | 2002-12-01 | Nagashimada et al. | Applicant |
| US6498043(B1) | 2002-12-01 | Schulman et al. | Applicant |
| US6514718(B2) | 2003-02-01 | Heller et al. | Applicant |
| US6520326(B2) | 2003-02-01 | McIvor et al. | Examiner |
| US6544212(B2) | 2003-04-01 | Galley et al. | Applicant |
| US6551494(B1) | 2003-04-01 | Heller et al. | Applicant |
| US6554798(B1) | 2003-04-01 | Mann et al. | Applicant |
| US6558321(B1) | 2003-05-01 | Burd et al. | Applicant |
| US6558351(B1) | 2003-05-01 | Steil et al. | Applicant |
| US6560471(B1) | 2003-05-01 | Heller et al. | Applicant |
| US6561978(B1) | 2003-05-01 | Conn et al. | Applicant |
| US6562001(B2) | 2003-05-01 | Lebel et al. | Applicant |
| US6564105(B2) | 2003-05-01 | Starkweather et al. | Applicant |
| US6565509(B1) | 2003-05-01 | Say et al. | Applicant |
| US6571128(B2) | 2003-05-01 | Lebel et al. | Applicant |
| US6572545(B2) | 2003-06-01 | Knobbe et al. | Applicant |
| US6576101(B1) | 2003-06-01 | Heller et al. | Applicant |
| US6577899(B2) | 2003-06-01 | Lebel et al. | Applicant |
| US6579690(B1) | 2003-06-01 | Bonnecaze et al. | Applicant |
| US6585644(B2) | 2003-07-01 | Lebel et al. | Applicant |
| US6591125(B1) | 2003-07-01 | Buse et al. | Applicant |
| US6595919(B2) | 2003-07-01 | Berner et al. | Applicant |
| US6605200(B1) | 2003-08-01 | Mao et al. | Applicant |
| US6605201(B1) | 2003-08-01 | Mao et al. | Applicant |
| US6607509(B2) | 2003-08-01 | Bobroff et al. | Applicant |
| US6610012(B2) | 2003-08-01 | Mault | Applicant |
| US6633772(B2) | 2003-10-01 | Ford et al. | Applicant |
| US6635014(B2) | 2003-10-01 | Starkweather et al. | Applicant |
| US6648821(B2) | 2003-11-01 | Lebel et al. | Applicant |
| US6654625(B1) | 2003-11-01 | Say et al. | Applicant |
| US6656114(B1) | 2003-12-01 | Poulsen et al. | Applicant |
| US6658396(B1) | 2003-12-01 | Tang et al. | Applicant |
| US6659948(B2) | 2003-12-01 | Lebel et al. | Applicant |
| US6668196(B1) | 2003-12-01 | Villegas et al. | Applicant |
| US6675030(B2) | 2004-01-01 | Ciuczak et al. | Applicant |
| US6676816(B2) | 2004-01-01 | Mao et al. | Applicant |
| US6687546(B2) | 2004-02-01 | Lebel et al. | Applicant |
| US6689056(B1) | 2004-02-01 | Kilcoyne et al. | Applicant |
| US6694191(B2) | 2004-02-01 | Starkweather et al. | Applicant |
| US6695860(B1) | 2004-02-01 | Ward et al. | Applicant |
| US6698269(B2) | 2004-03-01 | Baber et al. | Applicant |
| US6702857(B2) | 2004-03-01 | Brauker et al. | Applicant |
| US6733446(B2) | 2004-05-01 | Lebel et al. | Applicant |
| US6740075(B2) | 2004-05-01 | Lebel et al. | Applicant |
| US6740518(B1) | 2004-05-01 | Duong et al. | Applicant |
| US6741877(B1) | 2004-05-01 | Shults et al. | Applicant |
| US6746582(B2) | 2004-06-01 | Heller et al. | Applicant |
| US6758810(B2) | 2004-07-01 | Lebel et al. | Applicant |
| US6770030(B1) | 2004-08-01 | Schaupp et al. | Applicant |
| US6790178(B1) | 2004-09-01 | Mault et al. | Applicant |
| US6809653(B1) | 2004-10-01 | Mann et al. | Applicant |
| US6810290(B2) | 2004-10-01 | Lebel et al. | Applicant |
| US6811533(B2) | 2004-11-01 | Lebel et al. | Applicant |
| US6811534(B2) | 2004-11-01 | Bowman, IV et al. | Applicant |
| US6813519(B2) | 2004-11-01 | Lebel et al. | Applicant |
| US6862465(B2) | 2005-03-01 | Shults et al. | Applicant |
| US6865407(B2) | 2005-03-01 | Kimball et al. | Applicant |
| US6873268(B2) | 2005-03-01 | Lebel et al. | Applicant |
| US6881551(B2) | 2005-04-01 | Heller et al. | Applicant |
| US6882940(B2) | 2005-04-01 | Potts et al. | Applicant |
| US6892085(B2) | 2005-05-01 | McIvor et al. | Applicant |
| US6895263(B2) | 2005-05-01 | Shin et al. | Applicant |
| US6895265(B2) | 2005-05-01 | Silver | Applicant |
| US6931327(B2) | 2005-08-01 | Goode, Jr. et al. | Applicant |
| US6932894(B2) | 2005-08-01 | Mao et al. | Applicant |
| US6936006(B2) | 2005-08-01 | Sabra | Applicant |
| US6950708(B2) | 2005-09-01 | Bowman, IV et al. | Applicant |
| US6958705(B2) | 2005-10-01 | Lebel et al. | Applicant |
| US6968294(B2) | 2005-11-01 | Gutta et al. | Applicant |
| US6971274(B2) | 2005-12-01 | Olin | Applicant |
| US6974437(B2) | 2005-12-01 | Lebel et al. | Applicant |
| US6983176(B2) | 2006-01-01 | Gardner et al. | Applicant |
| US6990366(B2) | 2006-01-01 | Say et al. | Applicant |
| US6997907(B2) | 2006-02-01 | Safabash et al. | Applicant |
| US6998247(B2) | 2006-02-01 | Monfre et al. | Applicant |
| US7003336(B2) | 2006-02-01 | Holker et al. | Applicant |
| US7003340(B2) | 2006-02-01 | Say et al. | Applicant |
| US7003341(B2) | 2006-02-01 | Say et al. | Applicant |
| US7022072(B2) | 2006-04-01 | Fox et al. | Applicant |
| US7024245(B2) | 2006-04-01 | Lebel et al. | Applicant |
| US7025425(B2) | 2006-04-01 | Kovatchev et al. | Applicant |
| US7027848(B2) | 2006-04-01 | Robinson et al. | Applicant |
| US7027931(B1) | 2006-04-01 | Jones et al. | Applicant |
| US7029444(B2) | 2006-04-01 | Shin et al. | Applicant |
| US7041068(B2) | 2006-05-01 | Freeman et al. | Applicant |
| US7052483(B2) | 2006-05-01 | Wojcik | Applicant |
| US7056302(B2) | 2006-06-01 | Douglas | Applicant |
| US7074307(B2) | 2006-07-01 | Simpson et al. | Applicant |
| US7081195(B2) | 2006-07-01 | Simpson et al. | Applicant |
| US7092891(B2) | 2006-08-01 | Maus et al. | Applicant |
| US7098803(B2) | 2006-08-01 | Mann et al. | Applicant |
| US7108778(B2) | 2006-09-01 | Simpson et al. | Applicant |
| US7110803(B2) | 2006-09-01 | Shults et al. | Applicant |
| US7113821(B1) | 2006-09-01 | Sun et al. | Applicant |
| US7118667(B2) | 2006-10-01 | Lee | Applicant |
| US7134999(B2) | 2006-11-01 | Brauker et al. | Applicant |
| US7136689(B2) | 2006-11-01 | Shults et al. | Applicant |
| US7153265(B2) | 2006-12-01 | Vachon | Applicant |
| US7171274(B2) | 2007-01-01 | Starkweather et al. | Applicant |
| US7190988(B2) | 2007-03-01 | Say et al. | Applicant |
| US7192450(B2) | 2007-03-01 | Brauker et al. | Applicant |
| US7198606(B2) | 2007-04-01 | Boecker et al. | Applicant |
| US7225535(B2) | 2007-06-01 | Feldman et al. | Applicant |
| US7226978(B2) | 2007-06-01 | Tapsak et al. | Applicant |
| US7258673(B2) | 2007-08-01 | Racchini et al. | Applicant |
| US7267665(B2) | 2007-09-01 | Steil et al. | Applicant |
| US7276029(B2) | 2007-10-01 | Goode, Jr. et al. | Applicant |
| US7278983(B2) | 2007-10-01 | Ireland et al. | Applicant |
| US7299082(B2) | 2007-11-01 | Feldman et al. | Applicant |
| US7310544(B2) | 2007-12-01 | Brister et al. | Applicant |
| US7317938(B2) | 2008-01-01 | Lorenz et al. | Applicant |
| US7335294(B2) | 2008-02-01 | Heller et al. | Applicant |
| US7354420(B2) | 2008-04-01 | Steil et al. | Applicant |
| US7364592(B2) | 2008-04-01 | Carr-Brendel et al. | Applicant |
| US7366556(B2) | 2008-04-01 | Brister et al. | Applicant |
| US7379765(B2) | 2008-05-01 | Petisce et al. | Applicant |
| US7399277(B2) | 2008-07-01 | Saidara et al. | Examiner |
| US7402153(B2) | 2008-07-01 | Steil et al. | Applicant |
| US7404796(B2) | 2008-07-01 | Ginsberg | Applicant |
| US7424318(B2) | 2008-09-01 | Brister et al. | Applicant |
| US7460898(B2) | 2008-12-01 | Brister et al. | Applicant |
| US7467003(B2) | 2008-12-01 | Brister et al. | Applicant |
| US7471972(B2) | 2008-12-01 | Rhodes et al. | Applicant |
| US7474992(B2) | 2009-01-01 | Ariyur | Applicant |
| US7494465(B2) | 2009-02-01 | Brister et al. | Applicant |
| US7497827(B2) | 2009-03-01 | Brister et al. | Applicant |
| US7519408(B2) | 2009-04-01 | Rasdal et al. | Applicant |
| US7547281(B2) | 2009-06-01 | Hayes et al. | Applicant |
| US7569030(B2) | 2009-08-01 | Lebel et al. | Applicant |
| US7583990(B2) | 2009-09-01 | Goode, Jr. et al. | Applicant |
| US7591801(B2) | 2009-09-01 | Brauker et al. | Applicant |
| US7599726(B2) | 2009-10-01 | Goode, Jr. et al. | Applicant |
| US7613491(B2) | 2009-11-01 | Boock et al. | Applicant |
| US7615007(B2) | 2009-11-01 | Shults et al. | Applicant |
| US7618369(B2) | 2009-11-01 | Hayter et al. | Applicant |
| US7630748(B2) | 2009-12-01 | Budiman | Applicant |
| US7632228(B2) | 2009-12-01 | Brauker et al. | Applicant |
| US7637868(B2) | 2009-12-01 | Saint et al. | Applicant |
| US7640048(B2) | 2009-12-01 | Dobbles et al. | Applicant |
| US7647237(B2) | 2010-01-01 | Malave et al. | Examiner |
| US7651596(B2) | 2010-01-01 | Petisce et al. | Applicant |
| US7653425(B2) | 2010-01-01 | Hayter et al. | Applicant |
| US7654956(B2) | 2010-02-01 | Brister et al. | Applicant |
| US7657297(B2) | 2010-02-01 | Simpson et al. | Applicant |
| US7699964(B2) | 2010-04-01 | Feldman et al. | Applicant |
| US7711402(B2) | 2010-05-01 | Shults et al. | Applicant |
| US7713574(B2) | 2010-05-01 | Brister et al. | Applicant |
| US7715893(B2) | 2010-05-01 | Kamath et al. | Applicant |
| US7766830(B2) | 2010-08-01 | Fox et al. | Examiner |
| US7768386(B2) | 2010-08-01 | Hayter et al. | Applicant |
| US7778680(B2) | 2010-08-01 | Goode et al. | Applicant |
| US7920906(B2) | 2011-04-01 | Goode et al. | Applicant |
| US7920907(B2) | 2011-04-01 | McGarraugh et al. | Examiner |
| US7928850(B2) | 2011-04-01 | Hayter et al. | Applicant |
| US7976466(B2) | 2011-07-01 | Ward et al. | Applicant |
| US7985330(B2) | 2011-07-01 | Wang et al. | Examiner |
| US8010174(B2) | 2011-08-01 | Goode et al. | Applicant |
| US8114268(B2) | 2012-02-01 | Wang et al. | Examiner |
| US8114269(B2) | 2012-02-01 | Cooper et al. | Examiner |
| US2002/0019022(A1) | 2002-02-01 | Dunn et al. | Applicant |
| US2002/0042090(A1) | 2002-04-01 | Heller et al. | Applicant |
| US2002/0054320(A1) | 2002-05-01 | Ogino | Applicant |
| US2002/0068860(A1) | 2002-06-01 | Clark | Applicant |
| US2002/0103499(A1) | 2002-08-01 | Perez et al. | Applicant |
| US2002/0106709(A1) | 2002-08-01 | Potts et al. | Applicant |
| US2002/0128594(A1) | 2002-09-01 | Das et al. | Applicant |
| US2002/0161288(A1) | 2002-10-01 | Shin et al. | Applicant |
| US2002/0169635(A1) | 2002-11-01 | Shillingburg | Applicant |
| US2003/0004403(A1) | 2003-01-01 | Drinan et al. | Applicant |
| US2003/0023317(A1) | 2003-01-01 | Brauker et al. | Applicant |
| US2003/0032874(A1) | 2003-02-01 | Rhodes et al. | Applicant |
| US2003/0042137(A1) | 2003-03-01 | Mao et al. | Applicant |
| US2003/0060692(A1) | 2003-03-01 | Ruchti et al. | Applicant |
| US2003/0065308(A1) | 2003-04-01 | Lebel et al. | Applicant |
| US2003/0100821(A1) | 2003-05-01 | Heller et al. | Applicant |
| US2003/0125612(A1) | 2003-07-01 | Fox et al. | Examiner |
| US2003/0130616(A1) | 2003-07-01 | Steil et al. | Applicant |
| US2003/0134347(A1) | 2003-07-01 | Heller et al. | Applicant |
| US2003/0147515(A1) | 2003-08-01 | Kai et al. | Applicant |
| US2003/0168338(A1) | 2003-09-01 | Gao et al. | Applicant |
| US2003/0176933(A1) | 2003-09-01 | Lebel et al. | Applicant |
| US2003/0187338(A1) | 2003-10-01 | Say et al. | Applicant |
| US2003/0191377(A1) | 2003-10-01 | Robinson et al. | Applicant |
| US2003/0199790(A1) | 2003-10-01 | Boecker et al. | Applicant |
| US2003/0208113(A1) | 2003-11-01 | Mault et al. | Applicant |
| US2003/0212317(A1) | 2003-11-01 | Kovatchev et al. | Applicant |
| US2003/0212379(A1) | 2003-11-01 | Bylund et al. | Applicant |
| US2003/0216630(A1) | 2003-11-01 | Jersey-Willuhn et al. | Applicant |
| US2003/0217966(A1) | 2003-11-01 | Tapsak et al. | Applicant |
| US2004/0010186(A1) | 2004-01-01 | Kimball et al. | Examiner |
| US2004/0010207(A1) | 2004-01-01 | Flaherty et al. | Applicant |
| US2004/0011671(A1) | 2004-01-01 | Shults et al. | Applicant |
| US2004/0024553(A1) | 2004-02-01 | Monfre et al. | Applicant |
| US2004/0039298(A1) | 2004-02-01 | Abreu | Applicant |
| US2004/0040840(A1) | 2004-03-01 | Mao et al. | Applicant |
| US2004/0045879(A1) | 2004-03-01 | Shults et al. | Applicant |
| US2004/0064068(A1) | 2004-04-01 | DeNuzzio et al. | Applicant |
| US2004/0099529(A1) | 2004-05-01 | Mao et al. | Applicant |
| US2004/0106858(A1) | 2004-06-01 | Say et al. | Applicant |
| US2004/0122353(A1) | 2004-06-01 | Shahmirian et al. | Applicant |
| US2004/0133164(A1) | 2004-07-01 | Funderburk et al. | Applicant |
| US2004/0138588(A1) | 2004-07-01 | Saikley et al. | Applicant |
| US2004/0146909(A1) | 2004-07-01 | Duong et al. | Applicant |
| US2004/0152622(A1) | 2004-08-01 | Keith et al. | Applicant |
| US2004/0167464(A1) | 2004-08-01 | Ireland et al. | Applicant |
| US2004/0167801(A1) | 2004-08-01 | Say et al. | Applicant |
| US2004/0171921(A1) | 2004-09-01 | Say et al. | Applicant |
| US2004/0176672(A1) | 2004-09-01 | Silver et al. | Applicant |
| US2004/0186362(A1) | 2004-09-01 | Brauker et al. | Applicant |
| US2004/0186365(A1) | 2004-09-01 | Jin et al. | Applicant |
| US2004/0193025(A1) | 2004-09-01 | Steil et al. | Applicant |
| US2004/0193090(A1) | 2004-09-01 | Lebel et al. | Applicant |
| US2004/0197846(A1) | 2004-10-01 | Hockersmith et al. | Applicant |
| US2004/0199059(A1) | 2004-10-01 | Brauker et al. | Applicant |
| US2004/0204687(A1) | 2004-10-01 | Mogensen et al. | Applicant |
| US2004/0204868(A1) | 2004-10-01 | Maynard et al. | Applicant |
| US2004/0219664(A1) | 2004-11-01 | Heller et al. | Applicant |
| US2004/0225338(A1) | 2004-11-01 | Lebel et al. | Applicant |
| US2004/0236200(A1) | 2004-11-01 | Say et al. | Applicant |
| US2004/0254433(A1) | 2004-12-01 | Bandis et al. | Applicant |
| US2004/0260478(A1) | 2004-12-01 | Schwamm | Applicant |
| US2004/0267300(A1) | 2004-12-01 | Mace | Applicant |
| US2005/0004439(A1) | 2005-01-01 | Shin et al. | Applicant |
| US2005/0004494(A1) | 2005-01-01 | Perez et al. | Applicant |
| US2005/0010269(A1) | 2005-01-01 | Lebel et al. | Applicant |
| US2005/0027177(A1) | 2005-02-01 | Shin et al. | Applicant |
| US2005/0027180(A1) | 2005-02-01 | Goode et al. | Applicant |
| US2005/0027181(A1) | 2005-02-01 | Goode et al. | Applicant |
| US2005/0027462(A1) | 2005-02-01 | Goode et al. | Applicant |
| US2005/0027463(A1) | 2005-02-01 | Goode et al. | Applicant |
| US2005/0031689(A1) | 2005-02-01 | Shults et al. | Applicant |
| US2005/0038332(A1) | 2005-02-01 | Saidara et al. | Applicant |
| US2005/0043598(A1) | 2005-02-01 | Goode, Jr. et al. | Applicant |
| US2005/0070777(A1) | 2005-03-01 | Cho et al. | Applicant |
| US2005/0090607(A1) | 2005-04-01 | Tapsak et al. | Applicant |
| US2005/0096511(A1) | 2005-05-01 | Fox et al. | Applicant |
| US2005/0096512(A1) | 2005-05-01 | Fox et al. | Applicant |
| US2005/0112169(A1) | 2005-05-01 | Brauker et al. | Applicant |
| US2005/0113653(A1) | 2005-05-01 | Fox et al. | Applicant |
| US2005/0114068(A1) | 2005-05-01 | Chey et al. | Applicant |
| US2005/0121322(A1) | 2005-06-01 | Say et al. | Applicant |
| US2005/0131346(A1) | 2005-06-01 | Douglas | Applicant |
| US2005/0137530(A1) | 2005-06-01 | Campbell et al. | Applicant |
| US2005/0143635(A1) | 2005-06-01 | Kamath et al. | Applicant |
| US2005/0176136(A1) | 2005-08-01 | Burd et al. | Applicant |
| US2005/0177398(A1) | 2005-08-01 | Watanabe et al. | Applicant |
| US2005/0182306(A1) | 2005-08-01 | Sloan | Applicant |
| US2005/0187720(A1) | 2005-08-01 | Goode, Jr. et al. | Applicant |
| US2005/0192494(A1) | 2005-09-01 | Ginsberg | Applicant |
| US2005/0192557(A1) | 2005-09-01 | Brauker et al. | Applicant |
| US2005/0195930(A1) | 2005-09-01 | Spital et al. | Applicant |
| US2005/0199494(A1) | 2005-09-01 | Say et al. | Applicant |
| US2005/0203360(A1) | 2005-09-01 | Brauker et al. | Applicant |
| US2005/0239154(A1) | 2005-10-01 | Feldman et al. | Applicant |
| US2005/0241957(A1) | 2005-11-01 | Mao et al. | Applicant |
| US2005/0245795(A1) | 2005-11-01 | Goode, Jr. et al. | Applicant |
| US2005/0245799(A1) | 2005-11-01 | Brauker et al. | Applicant |
| US2005/0245839(A1) | 2005-11-01 | Stivoric et al. | Applicant |
| US2005/0245904(A1) | 2005-11-01 | Estes et al. | Applicant |
| US2005/0272985(A1) | 2005-12-01 | Kotulla et al. | Applicant |
| US2005/0287620(A1) | 2005-12-01 | Heller et al. | Applicant |
| US2006/0001538(A1) | 2006-01-01 | Kraft et al. | Applicant |
| US2006/0004270(A1) | 2006-01-01 | Bedard et al. | Applicant |
| US2006/0015020(A1) | 2006-01-01 | Neale et al. | Applicant |
| US2006/0015024(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0016700(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0017923(A1) | 2006-01-01 | Ruchti et al. | Applicant |
| US2006/0019327(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0020186(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0020187(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0020188(A1) | 2006-01-01 | Kamath et al. | Applicant |
| US2006/0020189(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0020190(A1) | 2006-01-01 | Kamath et al. | Applicant |
| US2006/0020191(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0020192(A1) | 2006-01-01 | Brister et al. | Applicant |
| US2006/0025663(A1) | 2006-02-01 | Talbot et al. | Applicant |
| US2006/0029177(A1) | 2006-02-01 | Cranford, Jr. et al. | Applicant |
| US2006/0031094(A1) | 2006-02-01 | Cohen et al. | Applicant |
| US2006/0036139(A1) | 2006-02-01 | Brister et al. | Applicant |
| US2006/0036140(A1) | 2006-02-01 | Brister et al. | Applicant |
| US2006/0036141(A1) | 2006-02-01 | Kamath et al. | Applicant |
| US2006/0036142(A1) | 2006-02-01 | Brister et al. | Applicant |
| US2006/0036143(A1) | 2006-02-01 | Brister et al. | Applicant |
| US2006/0036144(A1) | 2006-02-01 | Brister et al. | Applicant |
| US2006/0036145(A1) | 2006-02-01 | Brister et al. | Applicant |
| US2006/0155180(A1) | 2006-07-01 | Brister et al. | Applicant |
| US2006/0156796(A1) | 2006-07-01 | Burke et al. | Applicant |
| US2006/0166629(A1) | 2006-07-01 | Reggiardo | Applicant |
| US2006/0173260(A1) | 2006-08-01 | Gaoni et al. | Applicant |
| US2006/0173406(A1) | 2006-08-01 | Hayes et al. | Applicant |
| US2006/0173444(A1) | 2006-08-01 | Choy et al. | Applicant |
| US2006/0183985(A1) | 2006-08-01 | Brister et al. | Applicant |
| US2006/0189863(A1) | 2006-08-01 | Peyser et al. | Applicant |
| US2006/0211072(A1) | 2006-09-01 | Ryan et al. | Applicant |
| US2006/0222566(A1) | 2006-10-01 | Brauker et al. | Applicant |
| US2006/0224109(A1) | 2006-10-01 | Steil et al. | Applicant |
| US2006/0229512(A1) | 2006-10-01 | Petisce et al. | Applicant |
| US2006/0247508(A1) | 2006-11-01 | Fennell | Applicant |
| US2006/0253296(A1) | 2006-11-01 | Liisberg et al. | Applicant |
| US2006/0272652(A1) | 2006-12-01 | Stocker et al. | Applicant |
| US2006/0281985(A1) | 2006-12-01 | Ward et al. | Applicant |
| US2007/0010950(A1) | 2007-01-01 | Abensour et al. | Applicant |
| US2007/0016381(A1) | 2007-01-01 | Kamath et al. | Applicant |
| US2007/0027381(A1) | 2007-02-01 | Stafford | Applicant |
| US2007/0032706(A1) | 2007-02-01 | Kamath et al. | Applicant |
| US2007/0033074(A1) | 2007-02-01 | Nitzan et al. | Applicant |
| US2007/0060803(A1) | 2007-03-01 | Liljeryd et al. | Applicant |
| US2007/0060814(A1) | 2007-03-01 | Stafford | Applicant |
| US2007/0060979(A1) | 2007-03-01 | Strother et al. | Applicant |
| US2007/0066873(A1) | 2007-03-01 | Kamath et al. | Applicant |
| US2007/0066956(A1) | 2007-03-01 | Finkel | Applicant |
| US2007/0071681(A1) | 2007-03-01 | Gadkar et al. | Applicant |
| US2007/0073129(A1) | 2007-03-01 | Shah et al. | Applicant |
| US2007/0078320(A1) | 2007-04-01 | Stafford | Applicant |
| US2007/0078321(A1) | 2007-04-01 | Mazza et al. | Applicant |
| US2007/0078322(A1) | 2007-04-01 | Stafford | Applicant |
| US2007/0078323(A1) | 2007-04-01 | Reggiardo et al. | Applicant |
| US2007/0078818(A1) | 2007-04-01 | Zvitz et al. | Applicant |
| US2007/0093786(A1) | 2007-04-01 | Goldsmith et al. | Applicant |
| US2007/0094216(A1) | 2007-04-01 | Mathias et al. | Applicant |
| US2007/0100222(A1) | 2007-05-01 | Mastrototaro et al. | Applicant |
| US2007/0106135(A1) | 2007-05-01 | Sloan et al. | Applicant |
| US2007/0118405(A1) | 2007-05-01 | Campbell et al. | Applicant |
| US2007/0124002(A1) | 2007-05-01 | Estes et al. | Applicant |
| US2007/0149875(A1) | 2007-06-01 | Ouyang et al. | Applicant |
| US2007/0163880(A1) | 2007-07-01 | Woo et al. | Applicant |
| US2007/0168224(A1) | 2007-07-01 | Letzt et al. | Applicant |
| US2007/0173706(A1) | 2007-07-01 | Neinast et al. | Applicant |
| US2007/0173761(A1) | 2007-07-01 | Kanderian et al. | Applicant |
| US2007/0179349(A1) | 2007-08-01 | Hoyme et al. | Applicant |
| US2007/0179352(A1) | 2007-08-01 | Randlov et al. | Applicant |
| US2007/0191701(A1) | 2007-08-01 | Feldman et al. | Applicant |
| US2007/0203407(A1) | 2007-08-01 | Hoss et al. | Applicant |
| US2007/0203966(A1) | 2007-08-01 | Brauker et al. | Applicant |
| US2007/0208246(A1) | 2007-09-01 | Brauker et al. | Applicant |
| US2007/0213657(A1) | 2007-09-01 | Jennewine et al. | Applicant |
| US2007/0228071(A1) | 2007-10-01 | Kamen et al. | Applicant |
| US2007/0235331(A1) | 2007-10-01 | Simpson et al. | Applicant |
| US2007/0249922(A1) | 2007-10-01 | Peyser et al. | Applicant |
| US2007/0271285(A1) | 2007-11-01 | Eichorn et al. | Applicant |
| US2007/0282299(A1) | 2007-12-01 | Hellwig | Applicant |
| US2007/0299617(A1) | 2007-12-01 | Willis | Applicant |
| US2008/0009692(A1) | 2008-01-01 | Stafford | Applicant |
| US2008/0017522(A1) | 2008-01-01 | Heller et al. | Applicant |
| US2008/0021436(A1) | 2008-01-01 | Wolpert et al. | Applicant |
| US2008/0021666(A1) | 2008-01-01 | Goode, Jr. et al. | Applicant |
| US2008/0029391(A1) | 2008-02-01 | Mao et al. | Applicant |
| US2008/0033254(A1) | 2008-02-01 | Kamath et al. | Applicant |
| US2008/0039702(A1) | 2008-02-01 | Hayter et al. | Applicant |
| US2008/0045824(A1) | 2008-02-01 | Tapsak et al. | Applicant |
| US2008/0058625(A1) | 2008-03-01 | McGarraugh et al. | Applicant |
| US2008/0064937(A1) | 2008-03-01 | McGarraugh et al. | Applicant |
| US2008/0071156(A1) | 2008-03-01 | Brister et al. | Applicant |
| US2008/0071157(A1) | 2008-03-01 | McGarraugh et al. | Applicant |
| US2008/0071158(A1) | 2008-03-01 | McGarraugh et al. | Applicant |
| US2008/0081977(A1) | 2008-04-01 | Hayter et al. | Applicant |
| US2008/0083617(A1) | 2008-04-01 | Simpson et al. | Applicant |
| US2008/0086042(A1) | 2008-04-01 | Brister et al. | Applicant |
| US2008/0086044(A1) | 2008-04-01 | Brister et al. | Applicant |
| US2008/0086273(A1) | 2008-04-01 | Shults et al. | Applicant |
| US2008/0097289(A1) | 2008-04-01 | Steil et al. | Applicant |
| US2008/0108942(A1) | 2008-05-01 | Brister et al. | Applicant |
| US2008/0154513(A1) | 2008-06-01 | Kovatchev et al. | Applicant |
| US2008/0161666(A1) | 2008-07-01 | Feldman et al. | Applicant |
| US2008/0167543(A1) | 2008-07-01 | Say et al. | Applicant |
| US2008/0172205(A1) | 2008-07-01 | Breton et al. | Applicant |
| US2008/0182537(A1) | 2008-07-01 | Manku et al. | Applicant |
| US2008/0183060(A1) | 2008-07-01 | Steil et al. | Applicant |
| US2008/0183061(A1) | 2008-07-01 | Goode et al. | Applicant |
| US2008/0183399(A1) | 2008-07-01 | Goode et al. | Applicant |
| US2008/0188731(A1) | 2008-08-01 | Brister et al. | Applicant |
| US2008/0188796(A1) | 2008-08-01 | Steil et al. | Applicant |
| US2008/0189051(A1) | 2008-08-01 | Goode et al. | Applicant |
| US2008/0194935(A1) | 2008-08-01 | Brister et al. | Applicant |
| US2008/0194936(A1) | 2008-08-01 | Goode et al. | Applicant |
| US2008/0194937(A1) | 2008-08-01 | Goode et al. | Applicant |
| US2008/0194938(A1) | 2008-08-01 | Brister et al. | Applicant |
| US2008/0195232(A1) | 2008-08-01 | Carr-Brendel et al. | Applicant |
| US2008/0195967(A1) | 2008-08-01 | Goode et al. | Applicant |
| US2008/0197024(A1) | 2008-08-01 | Simpson et al. | Applicant |
| US2008/0200788(A1) | 2008-08-01 | Brister et al. | Applicant |
| US2008/0200789(A1) | 2008-08-01 | Brister et al. | Applicant |
| US2008/0200791(A1) | 2008-08-01 | Simpson et al. | Applicant |
| US2008/0208025(A1) | 2008-08-01 | Shults et al. | Applicant |
| US2008/0208026(A1) | 2008-08-01 | Noujaim et al. | Applicant |
| US2008/0208113(A1) | 2008-08-01 | Damiano et al. | Applicant |
| US2008/0214915(A1) | 2008-09-01 | Brister et al. | Applicant |
| US2008/0214918(A1) | 2008-09-01 | Brister et al. | Applicant |
| US2008/0228051(A1) | 2008-09-01 | Shults et al. | Applicant |
| US2008/0228054(A1) | 2008-09-01 | Shults et al. | Applicant |
| US2008/0228055(A1) | 2008-09-01 | Sher | Examiner |
| US2008/0234663(A1) | 2008-09-01 | Yodfat et al. | Applicant |
| US2008/0242961(A1) | 2008-10-01 | Brister et al. | Applicant |
| US2008/0255434(A1) | 2008-10-01 | Hayter et al. | Applicant |
| US2008/0255437(A1) | 2008-10-01 | Hayter | Applicant |
| US2008/0255808(A1) | 2008-10-01 | Hayter | Applicant |
| US2008/0256048(A1) | 2008-10-01 | Hayter | Applicant |
| US2008/0262469(A1) | 2008-10-01 | Brister et al. | Applicant |
| US2008/0269723(A1) | 2008-10-01 | Mastrototaro et al. | Applicant |
| US2008/0275313(A1) | 2008-11-01 | Brister et al. | Applicant |
| US2008/0287761(A1) | 2008-11-01 | Hayter | Applicant |
| US2008/0287762(A1) | 2008-11-01 | Hayter | Applicant |
| US2008/0287763(A1) | 2008-11-01 | Hayter | Applicant |
| US2008/0287764(A1) | 2008-11-01 | Rasdal et al. | Applicant |
| US2008/0287765(A1) | 2008-11-01 | Rasdal et al. | Applicant |
| US2008/0287766(A1) | 2008-11-01 | Rasdal et al. | Applicant |
| US2008/0288180(A1) | 2008-11-01 | Hayter | Applicant |
| US2008/0288204(A1) | 2008-11-01 | Hayter et al. | Applicant |
| US2008/0296155(A1) | 2008-12-01 | Shults et al. | Applicant |
| US2008/0306368(A1) | 2008-12-01 | Goode et al. | Applicant |
| US2008/0306434(A1) | 2008-12-01 | Dobbles et al. | Applicant |
| US2008/0306435(A1) | 2008-12-01 | Kamath et al. | Applicant |
| US2008/0306444(A1) | 2008-12-01 | Brister et al. | Applicant |
| US2008/0312841(A1) | 2008-12-01 | Hayter | Applicant |
| US2008/0312842(A1) | 2008-12-01 | Hayter | Applicant |
| US2008/0312844(A1) | 2008-12-01 | Hayter et al. | Applicant |
| US2008/0312845(A1) | 2008-12-01 | Hayter et al. | Applicant |
| US2008/0314395(A1) | 2008-12-01 | Kovatchev et al. | Applicant |
| US2008/0319279(A1) | 2008-12-01 | Ramsay et al. | Applicant |
| US2009/0005665(A1) | 2009-01-01 | Hayter et al. | Applicant |
| US2009/0006034(A1) | 2009-01-01 | Hayter et al. | Applicant |
| US2009/0006133(A1) | 2009-01-01 | Weinert et al. | Applicant |
| US2009/0012379(A1) | 2009-01-01 | Goode et al. | Applicant |
| US2009/0018424(A1) | 2009-01-01 | Kamath et al. | Applicant |
| US2009/0018425(A1) | 2009-01-01 | Ouyang et al. | Applicant |
| US2009/0030294(A1) | 2009-01-01 | Petisce et al. | Applicant |
| US2009/0033482(A1) | 2009-02-01 | Hayter et al. | Applicant |
| US2009/0036747(A1) | 2009-02-01 | Hayter et al. | Applicant |
| US2009/0036758(A1) | 2009-02-01 | Brauker et al. | Applicant |
| US2009/0036760(A1) | 2009-02-01 | Hayter | Applicant |
| US2009/0036763(A1) | 2009-02-01 | Brauker et al. | Applicant |
| US2009/0043181(A1) | 2009-02-01 | Brauker et al. | Applicant |
| US2009/0043182(A1) | 2009-02-01 | Brauker et al. | Applicant |
| US2009/0043525(A1) | 2009-02-01 | Brauker et al. | Applicant |
| US2009/0043541(A1) | 2009-02-01 | Brauker et al. | Applicant |
| US2009/0043542(A1) | 2009-02-01 | Brauker et al. | Applicant |
| US2009/0045055(A1) | 2009-02-01 | Rhodes et al. | Applicant |
| US2009/0055149(A1) | 2009-02-01 | Hayter et al. | Applicant |
| US2009/0062633(A1) | 2009-03-01 | Brauker et al. | Applicant |
| US2009/0062635(A1) | 2009-03-01 | Brauker et al. | Applicant |
| US2009/0062767(A1) | 2009-03-01 | VanAntwerp et al. | Applicant |
| US2009/0063402(A1) | 2009-03-01 | Hayter | Applicant |
| US2009/0076356(A1) | 2009-03-01 | Simpson et al. | Applicant |
| US2009/0076360(A1) | 2009-03-01 | Brister et al. | Applicant |
| US2009/0076361(A1) | 2009-03-01 | Kamath et al. | Applicant |
| US2009/0082693(A1) | 2009-03-01 | Stafford | Applicant |
| US2009/0088614(A1) | 2009-04-01 | Taub et al. | Applicant |
| US2009/0099436(A1) | 2009-04-01 | Brister et al. | Applicant |
| US2009/0105560(A1) | 2009-04-01 | Solomon | Applicant |
| US2009/0105636(A1) | 2009-04-01 | Hayter et al. | Applicant |
| US2009/0124877(A1) | 2009-05-01 | Goode et al. | Applicant |
| US2009/0124878(A1) | 2009-05-01 | Goode et al. | Applicant |
| US2009/0124879(A1) | 2009-05-01 | Brister et al. | Applicant |
| US2009/0124964(A1) | 2009-05-01 | Leach et al. | Applicant |
| US2009/0131768(A1) | 2009-05-01 | Simpson et al. | Applicant |
| US2009/0131769(A1) | 2009-05-01 | Leach et al. | Applicant |
| US2009/0131776(A1) | 2009-05-01 | Simpson et al. | Applicant |
| US2009/0131777(A1) | 2009-05-01 | Simpson et al. | Applicant |
| US2009/0137886(A1) | 2009-05-01 | Shariati et al. | Applicant |
| US2009/0137887(A1) | 2009-05-01 | Shariati et al. | Applicant |
| US2009/0143659(A1) | 2009-06-01 | Li et al. | Applicant |
| US2009/0143660(A1) | 2009-06-01 | Brister et al. | Applicant |
| US2009/0156919(A1) | 2009-06-01 | Brister et al. | Applicant |
| US2009/0156924(A1) | 2009-06-01 | Shariati et al. | Applicant |
| US2009/0163790(A1) | 2009-06-01 | Brister et al. | Applicant |
| US2009/0163791(A1) | 2009-06-01 | Brister et al. | Applicant |
| US2009/0164190(A1) | 2009-06-01 | Hayter | Applicant |
| US2009/0164239(A1) | 2009-06-01 | Hayter et al. | Applicant |
| US2009/0164251(A1) | 2009-06-01 | Hayter | Applicant |
| US2009/0178459(A1) | 2009-07-01 | Li et al. | Applicant |
| US2009/0182217(A1) | 2009-07-01 | Li et al. | Applicant |
| US2009/0192366(A1) | 2009-07-01 | Mensinger et al. | Applicant |
| US2009/0192380(A1) | 2009-07-01 | Shariati et al. | Applicant |
| US2009/0192722(A1) | 2009-07-01 | Shariati et al. | Applicant |
| US2009/0192724(A1) | 2009-07-01 | Brauker et al. | Applicant |
| US2009/0192745(A1) | 2009-07-01 | Kamath et al. | Applicant |
| US2009/0192751(A1) | 2009-07-01 | Kamath et al. | Applicant |
| US2009/0198118(A1) | 2009-08-01 | Hayter et al. | Applicant |
| US2009/0203981(A1) | 2009-08-01 | Brauker et al. | Applicant |
| US2009/0204341(A1) | 2009-08-01 | Brauker et al. | Applicant |
| US2009/0216103(A1) | 2009-08-01 | Brister et al. | Applicant |
| US2009/0227855(A1) | 2009-09-01 | Hill et al. | Applicant |
| US2009/0240120(A1) | 2009-09-01 | Mensinger et al. | Applicant |
| US2009/0240128(A1) | 2009-09-01 | Mensinger et al. | Applicant |
| US2009/0240193(A1) | 2009-09-01 | Mensinger et al. | Applicant |
| US2009/0240440(A1) | 2009-09-01 | Shurabura et al. | Applicant |
| US2009/0242399(A1) | 2009-10-01 | Kamath et al. | Applicant |
| US2009/0242425(A1) | 2009-10-01 | Kamath et al. | Applicant |
| US2009/0247855(A1) | 2009-10-01 | Boock et al. | Applicant |
| US2009/0247856(A1) | 2009-10-01 | Boock et al. | Applicant |
| US2009/0253973(A1) | 2009-10-01 | Bashan et al. | Applicant |
| US2009/0259118(A1) | 2009-10-01 | Feldman et al. | Applicant |
| US2009/0287073(A1) | 2009-11-01 | Boock et al. | Applicant |
| US2009/0287074(A1) | 2009-11-01 | Shults et al. | Applicant |
| US2009/0292188(A1) | 2009-11-01 | Hoss et al. | Applicant |
| US2009/0299155(A1) | 2009-12-01 | Yang et al. | Applicant |
| US2009/0299156(A1) | 2009-12-01 | Simpson et al. | Applicant |
| US2009/0299162(A1) | 2009-12-01 | Brauker et al. | Applicant |
| US2009/0299276(A1) | 2009-12-01 | Brauker et al. | Applicant |
| US2010/0010324(A1) | 2010-01-01 | Brauker et al. | Applicant |
| US2010/0010331(A1) | 2010-01-01 | Brauker et al. | Applicant |
| US2010/0010332(A1) | 2010-01-01 | Brauker et al. | Applicant |
| US2010/0016687(A1) | 2010-01-01 | Brauker et al. | Applicant |
| US2010/0016698(A1) | 2010-01-01 | Rasdal et al. | Applicant |
| US2010/0022855(A1) | 2010-01-01 | Brauker et al. | Applicant |
| US2010/0030038(A1) | 2010-02-01 | Brauker et al. | Applicant |
| US2010/0030053(A1) | 2010-02-01 | Goode, Jr. et al. | Applicant |
| US2010/0030484(A1) | 2010-02-01 | Brauker et al. | Applicant |
| US2010/0030485(A1) | 2010-02-01 | Brauker et al. | Applicant |
| US2010/0036215(A1) | 2010-02-01 | Goode, Jr. et al. | Applicant |
| US2010/0036216(A1) | 2010-02-01 | Goode, Jr. et al. | Applicant |
| US2010/0036222(A1) | 2010-02-01 | Goode, Jr. et al. | Applicant |
| US2010/0036223(A1) | 2010-02-01 | Goode, Jr. et al. | Applicant |
| US2010/0036225(A1) | 2010-02-01 | Goode, Jr. et al. | Applicant |
| US2010/0041971(A1) | 2010-02-01 | Goode, Jr. et al. | Applicant |
| US2010/0045465(A1) | 2010-02-01 | Brauker et al. | Applicant |
| US2010/0049024(A1) | 2010-02-01 | Saint et al. | Applicant |
| US2010/0056992(A1) | 2010-03-01 | Hayter et al. | Applicant |
| US2010/0057040(A1) | 2010-03-01 | Hayter | Applicant |
| US2010/0057041(A1) | 2010-03-01 | Hayter | Applicant |
| US2010/0057042(A1) | 2010-03-01 | Hayter | Applicant |
| US2010/0057044(A1) | 2010-03-01 | Hayter | Applicant |
| US2010/0057057(A1) | 2010-03-01 | Hayter et al. | Applicant |
| US2010/0063373(A1) | 2010-03-01 | Kamath et al. | Applicant |
| US2010/0075353(A1) | 2010-03-01 | Heaton | Examiner |
| US2010/0076283(A1) | 2010-03-01 | Simpson et al. | Applicant |
| US2010/0081906(A1) | 2010-04-01 | Hayter et al. | Applicant |
| US2010/0081908(A1) | 2010-04-01 | Dobbles et al. | Applicant |
| US2010/0081910(A1) | 2010-04-01 | Brister et al. | Applicant |
| US2010/0087724(A1) | 2010-04-01 | Brauker et al. | Applicant |
| US2010/0096259(A1) | 2010-04-01 | Zhang et al. | Applicant |
| US2010/0099970(A1) | 2010-04-01 | Shults et al. | Applicant |
| US2010/0099971(A1) | 2010-04-01 | Shults et al. | Applicant |
| US2010/0105999(A1) | 2010-04-01 | Dixon et al. | Applicant |
| US2010/0119693(A1) | 2010-05-01 | Tapsak et al. | Applicant |
| US2010/0121169(A1) | 2010-05-01 | Petisce et al. | Applicant |
| US2010/0152554(A1) | 2010-06-01 | Steine et al. | Applicant |
| US2010/0168546(A1) | 2010-07-01 | Kamath et al. | Applicant |
| US2010/0191082(A1) | 2010-07-01 | Brister et al. | Applicant |
| US2010/0198142(A1) | 2010-08-01 | Sloan et al. | Applicant |
| US2010/0240975(A1) | 2010-09-01 | Goode et al. | Applicant |
| US2010/0312176(A1) | 2010-12-01 | Lauer et al. | Applicant |
| AU2003/259741 | 2004-02-01 | Applicant | |
| CA2495648 | 2004-02-01 | Applicant | |
| CA2498682 | 2005-09-01 | Applicant | |
| CA2555749 | 2005-09-01 | Applicant | |
| CA2632709 | 2007-06-01 | Applicant | |
| CA2615575 | 2008-06-01 | Applicant | |
| CA2701374 | 2009-04-01 | Applicant | |
| DE4401400 | 1995-07-01 | Applicant | |
| EP98592 | 1984-01-01 | Applicant | |
| EP127958 | 1984-12-01 | Applicant | |
| EP320109 | 1989-06-01 | Applicant | |
| EP353328 | 1990-02-01 | Applicant | |
| EP390390 | 1990-10-01 | Applicant | |
| EP396788 | 1990-11-01 | Applicant | |
| EP286118 | 1995-01-01 | Applicant | |
| EP1048264 | 2000-11-01 | Applicant | |
| EP1568309 | 2005-08-01 | Applicant | |
| EP1956371 | 2008-08-01 | Applicant | |
| EP2260757 | 2010-12-01 | Applicant | |
| WO-93/06237 | 1993-04-01 | Applicant | |
| WO-96/25089 | 1996-08-01 | Applicant | |
| WO-96/35370 | 1996-11-01 | Applicant | |
| WO-98/35053 | 1998-08-01 | Applicant | |
| WO-99/56613 | 1999-11-01 | Applicant | |
| WO-00/49940 | 2000-08-01 | Applicant | |
| WO-00/59370 | 2000-10-01 | Applicant | |
| WO-00/074753 | 2000-12-01 | Applicant | |
| WO-00/78992 | 2000-12-01 | Applicant | |
| WO-01/52935 | 2001-07-01 | Applicant | |
| WO-01/54753 | 2001-08-01 | Applicant | |
| WO-02/16905 | 2002-02-01 | Applicant | |
| WO-02/058537 | 2002-08-01 | Applicant | |
| WO-03/076893 | 2003-09-01 | Applicant | |
| WO-03/082091 | 2003-10-01 | Applicant | |
| WO-03/085372 | 2003-10-01 | Applicant | |
| WO-2004/015539 | 2004-02-01 | Applicant | |
| WO-2004/061420 | 2004-07-01 | Applicant | |
| WO-2005/040404 | 2005-05-01 | Applicant | |
| WO-2005/041766 | 2005-05-01 | Applicant | |
| WO-2005/089103 | 2005-09-01 | Applicant | |
| WO-2006/024671 | 2006-03-01 | Applicant | |
| WO-2006/051466 | 2006-05-01 | Applicant | |
| WO-2006/079114 | 2006-07-01 | Applicant | |
| WO-2006/118947 | 2006-11-01 | Applicant | |
| WO-2007/007459 | 2007-01-01 | Applicant | |
| WO-2007/016399 | 2007-02-01 | Applicant | |
| WO-2007/027788 | 2007-03-01 | Applicant | |
| WO-2007/041069 | 2007-04-01 | Applicant | |
| WO-2007/041070 | 2007-04-01 | Applicant | |
| WO-2007/041248 | 2007-04-01 | Applicant | |
| WO-2007/056638 | 2007-05-01 | Applicant | |
| WO-2007/065285 | 2007-06-01 | Applicant | |
| WO-2007/101223 | 2007-09-01 | Applicant | |
| WO-2007/120363 | 2007-10-01 | Applicant | |
| WO-2007/126444 | 2007-11-01 | Applicant | |
| WO-2007/053832 | 2007-12-01 | Applicant | |
| WO-2007/143225 | 2007-12-01 | Applicant | |
| WO-2007/149319 | 2007-12-01 | Applicant | |
| WO-2008/001366 | 2008-01-01 | Applicant | |
| WO-2008/021913 | 2008-02-01 | Applicant | |
| WO-2008/042760 | 2008-04-01 | Applicant | |
| WO-2008/086541 | 2008-07-01 | Applicant | |
| WO-2008/128210 | 2008-10-01 | Applicant | |
| WO-2008/130896 | 2008-10-01 | Applicant | |
| WO-2008/130897 | 2008-10-01 | Applicant | |
| WO-2008/130898 | 2008-10-01 | Applicant | |
| WO-2008/143943 | 2008-11-01 | Applicant | |
| WO-2009/018058 | 2009-02-01 | Applicant | |
| WO-2009/086216 | 2009-07-01 | Applicant | |
| WO-2009/096992 | 2009-08-01 | Applicant | |
| WO-2009/097594 | 2009-08-01 | Applicant | |
| WO-2010/077329 | 2010-07-01 | Applicant | |
| WO-2011/104616 | 2011-09-01 | Applicant |
Non-Patent Literature (48)
- Armour, J. C., et al., “Application of Chronic Intravascular Blood Glucose Sensor in Dogs”, Diabetes, vol. 39, 1990, pp. 1519-1526.Applicant
- Bennion, N., et al., “Alternate Site Glucose Testing: A Crossover Design”, Diabetes Technology & Therapeutics, vol. 4, No. 1, 2002, pp. 25-33.Applicant
- Blank, T. B., et al., “Clinical Results From a Non-Invasive Blood Glucose Monitor”, Optical Diagnostics and Sensing of Biological Fluids and Glucose and Cholesterol Monitoring II, Proceedings of SPIE, vol. 4624, 2002, pp. 1-10.Applicant
- Brooks, S. L., et al., “Development of an On-Line Glucose Sensor for Fermentation Monitoring”, Biosensors, vol. 3, 1987/88, pp. 45-56.Applicant
- Cass, A. E., et al., “Ferrocene-Medicated Enzyme Electrode for Amperometric Determination of Glucose”, Analytical Chemistry, vol. 56, No. 4, 1984, 667-671.Applicant
- Csoregi, E., et al., “Design and Optimization of a Selective Subcutaneously Implantable Glucose Electrode Based on ‘Wired’ Glucose Oxidase”, Analytical Chemistry, vol. 67, No. 7, 1995, pp. 1240-1244.Applicant
- El-Khatib, F. H, et al., “Adaptive Closed-Loop Provides Blood-Glucose Regulation Using Subcutaneous Insulin and Glucagon Infusion in Diabetic Swine”, Journal of Diabetes Science and Technology, vol. 1, No. 2, 2007, pp. 181-192.Applicant
- Feldman, B., et al., “A Continuous Glucose Sensor Based on Wired Enzyme™ Technology—Results from a 3-Day Trial in Patients with Type 1 Diabetes”, Diabetes Technology & Therapeutics, vol. 5, No. 5, 2003, pp. 769-779.Applicant
- Feldman, B., et al., “Correlation of Glucose Concentrations in Interstitial Fluid and Venous Blood During Periods of Rapid Glucose Change”, Abbott Diabetes Care, Inc. Freestyle Navigator Continuous Glucose Monitor Pamphlet, 2004.Applicant
- Isermann, R., “Supervision, Fault-Detection and Fault-Diagnosis Methods—An Introduction”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 639-652.Applicant
- Isermann, R., et al., “Trends in the Application of Model-Based Fault Detection and Diagnosis of Technical Processes”, Control Engineering Practice, vol. 5, No. 5, 1997, pp. 709-719.Applicant
- Johnson, P. C., “Peripheral Circulation”, John Wiley & Sons, 1978, pp. 198.Applicant
- Jungheim, K., et al., “How Rapid Does Glucose Concentration Change in Daily Life of Patients with Type 1 Diabetes?”, 2002, pp. 250.Applicant
- Jungheim, K., et al., “Risky Delay of Hypoglycemia Detection by Glucose Monitoring at the Arm”, Diabetes Care, vol. 24, No. 7, 2001, pp. 1303-1304.Applicant
- Kaplan, S. M., “Wiley Electrical and Electronics Engineering Dictionary”, IEEE Press, 2004, pp. 141, 142, 548, 549.Applicant
- Lortz, J., et al., “What is Bluetooth? We Explain the Newest Short-Range Connectivity Technology”, Smart Computing Learning Series, Wireless Computing, vol. 8, Issue 5, 2002, pp. 72-74.Applicant
- Malin, S. F., et al., “Noninvasive Prediction of Glucose by Near-Infrared Diffuse Reflectance Spectoscopy”, Clinical Chemistry, vol. 45, No. 9, 1999, pp. 1651-1658.Applicant
- McGarraugh, G., et al., “Glucose Measurements Using Blood Extracted from the Forearm and the Finger”, TheraSense, Inc., 2001, 16 Pages.Applicant
- McGarraugh, G., et al., “Physiological Influences on Off-Finger Glucose Testing”, Diabetes Technology & Therapeutics, vol. 3, No. 3, 2001, pp. 367-376.Applicant
- McKean, B. D., et al., “A Telemetry-Instrumentation System for Chronically Implated Glucose and Oxygen Sensors”, IEEE Transactions on Biomedical Engineering, vol. 35, No. 7, 1988, pp. 526-532.Applicant
- Pickup, J., et al., “Implantable Glucose Sensors: Choosing the Appropriate Sensing Strategy”, Biosensors, vol. 3, 1987/88, pp. 335-346.Applicant
- Pickup, J., et al., “In Vivo Molecular Sensing in Diabetes Mellitus: An Implantable Glucose Sensor with Direct Electron Transfer”, Diabetologia, vol. 32, 1989, pp. 213-217.Applicant
- Pishko, M. V., et al., “Amperometric Glucose Microelectrodes Prepared Through Immobilization of Glucose Oxidase in Redox Hydrogels”, Analytical Chemistry, vol. 63, No. 20, 1991, pp. 2268-2272.Applicant
- Quinn, C. P., et al., “Kinetics of Glucose Delivery to Subcutaneous Tissue in Rats Measured with 0.3-mm Amperometric Microsensors”, The American Physiological Society, 1995, E155-E161.Applicant
- Roe, J. N., et al., “Bloodless Glucose Measurements”, Critical Review in Therapeutic Drug Carrier Systems, vol. 15, Issue 3, 1998, pp. 199-241.Applicant
- Sakakida, M., et al., “Development of Ferrocene-Mediated Needle-Type Glucose Sensor as a Measure of True Subcutaneous Tissue Glucose Concentrations”, Artificial Organs Today, vol. 2, No. 2, 1992, pp. 145-158.Applicant
- Sakakida, M., et al., “Ferrocene-Mediated Needle-Type Glucose Sensor Covered with Newly Designed Biocompatible Membrane”, Sensors and Actuators B, vol. 13-14, 1993, pp. 319-322.Applicant
- Salehi, C., et al., “A Telemetry-Instrumentation System for Long-Term Implantable Glucose and Oxygen Sensors”, Analytical Letters, vol. 29, No. 13, 1996, pp. 2289-2308.Applicant
- Schmidtke, D. W., et al., “Measurement and Modeling of the Transient Difference Between Blood and Subcutaneous Glucose Concentrations in the Rat After Injection of Insulin”, Proceedings of the National Academy of Sciences, vol. 95, 1998, pp. 294-299.Applicant
- Shaw, G. W., et al., “In Vitro Testing of a Simply Constructed, Highly Stable Glucose Sensor Suitable for Implantation in Diabetic Patients”, Biosensors & Bioelectronics, vol. 6, 1991, pp. 401-406.Applicant
- Shichiri, M., et al., “Glycaemic Control in Pancreatectomized Dogs with a Wearable Artificial Endocrine Pancreas”, Diabetologia, vol. 24, 1983, pp. 179-184.Applicant
- Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers”, Hormone and Metabolic Research Supplement Series, vol. 20, 1988, pp. 17-20.Applicant
- Shichiri, M., et al., “Membrane Design for Extending the Long-Life of an Implantable Glucose Sensor”, Diabetes Nutrition and Metabolism, vol. 2, 1989, pp. 309-313.Applicant
- Shichiri, M., et al., “Needle-type Glucose Sensor for Wearable Artificial Endocrine Pancreas”, Implantable Sensors for Closed-Loop Prosthetic Systems, Chapter 15, 1985, pp. 197-210.Applicant
- Shichiri, M., et al., “Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals”, Diabetes Care, vol. 9, No. 3, 1986, pp. 298-301.Applicant
- Shichiri, M., et al., “Wearable Artificial Endocrine Pancreas With Needle-Type Glucose Sensor”, The Lancet, 1982, pp. 1129-1131.Applicant
- Shults, M. C., et al., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors”, IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, 1994, pp. 937-942.Applicant
- Sternberg, R., et al., “Study and Development of Multilayer Needle-Type Enzyme-Based Glucose Microsensors”, Biosensors, vol. 4, 1988, pp. 27-40.Applicant
- Thompson, M., et al., “In Vivo Probes: Problems and Perspectives”, Clinical Biochemistry, vol. 19, 1986, pp. 255-261.Applicant
- Turner, A., et al., “Diabetes Mellitus: Biosensors for Research and Management”, Biosensors, vol. 1, 1985, pp. 85-115.Applicant
- Updike, S. J., et al., “Principles of Long-Term Fully Implanted Sensors with Emphasis on Radiotelemetric Monitoring of Blood Glucose from Inside a Subcutaneous Foreign Body Capsule (FBC)”, Biosensors in the Body: Continuous in vivo Monitoring, Chapter 4, 1997, pp. 117-137.Applicant
- Velho, G., et al., “Strategies for Calibrating a Subcutaneous Glucose Sensor”, Biomedica Biochimica Acta, vol. 48, 1989, pp. 957-964.Applicant
- Wilson, G. S., et al., “Progress Toward the Development of an Implantable Sensor for Glucose”, Clinical Chemistry, vol. 38, No. 9, 1992, pp. 1613-1617.Applicant
- Morbiducci, U, et al., “Improved Usability of the Minimal Model of Insulin Sensitivity Based on an Automated Approach and Genetic Algorithms for Parameter Estimation”, Clinical Science, vol. 112, 2007, pp. 257-263.Applicant
- Parker, R., et al., “Robust H∞ Glucose Control in Diabetes Using a Physiological Model”, AIChE Journal, vol. 46, No. 12, 2000, pp. 2537-2549.Applicant
- Aussedat, B., et al., “A User-Friendly Method for Calibrating a Subcutaneous Glucose Sensor-Based Hypoglycemic Alarm”, Biosensors & Bioelectronics, vol. 12, No. 11, 1997, pp. 1061-1070.Applicant
- Garg, S., et al., “Improvement in Glycemic Excursions with a Transcutaneous, Real-Time Continuous Glucose Sensor”, Diabetes Care, vol. 29, No. 1, 2006, pp. 44-50.Applicant
- Mougiakakou, et al., “A Real Time Simulation Model of Glucose-Insulin Metabolism for Type 1 Diabetes Patients”, Proceedings of the 2005 IEEE, 2005, pp. 298-301.Applicant